Greenwave Technology Solutions (GWAV) 10-K 16 Jul 20 2019 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2019	Jul. 10, 2020	Jun. 30, 2019
Document and Entity Information [Abstract]
Entity Registrant Name	MassRoots, Inc.
Entity Central Index Key	0001589149
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-K
Document Period End Date	Dec. 31, 2019
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2019
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding		493,726,405
Entity Incorporation State Country Code	DE
Entity File Number	000-55431
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Public Float			$ 2,572,563

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
CURRENT ASSETS
Cash	$ 1,120	$ 29,568
Prepaid expenses	1,975	14,000
TOTAL CURRENT ASSETS	3,095	43,568
Property and equipment - net		6,733
OTHER ASSETS
Investments		247,912
Software cost, net of amortization and impairment of $260,565 and $25,701, respectively		234,864
Deposits and other assets		36,000
Total Other Assets		518,776
TOTAL ASSETS	3,095	569,077
CURRENT LIABILITIES
Bank overdrafts	13,749
Accounts payable and accrued expenses	5,455,063	959,668
Accrued payroll and related expenses	3,724,050	2,992,023
Advances	337,500	932,500
Non-convertible notes payable	165,750	26,150
Derivative liability	20,236,870
Convertible notes payable, net of debt discount of $380,431 and $209,898, respectively	6,939,039	2,495,102
TOTAL CURRENT LIABILITIES	36,872,021	7,405,443
Commitments and Contingencies (See Note 11)
STOCKHOLDERS' DEFICIT
Common stock, $0.001 par value, 500,000,000 shares authorized; 384,266,948 and 168,706,472 shares issued and outstanding, respectively	384,267	168,707
Common stock to be issued, 944,659,814 and 80,000 shares, respectively	944,660	80
Additional paid in capital	151,364,371	73,770,195
Accumulated deficit	(189,562,225)	(80,775,348)
TOTAL STOCKHOLDERS' DEFICIT	(36,868,926)	(6,836,366)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	3,095	569,077
Series A Preferred Stock
STOCKHOLDERS' DEFICIT
Preferred stock
Series B Preferred Stock
STOCKHOLDERS' DEFICIT
Preferred stock
Series C Preferred Stock
STOCKHOLDERS' DEFICIT
Preferred stock	$ 1

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Net of amortization	$ 260,565	$ 25,701
Net of debt discount	$ 380,431	$ 209,898
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	384,266,948	168,706,472
Common stock, shares outstanding	384,266,948	168,706,472
Common stock to be issued	944,659,814	80,000
Series A Preferred Stock
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	6,000	6,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series B Preferred Stock
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	2,000	2,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series C Preferred Stock
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000	1,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

Consolidated Statement of Opera

Consolidated Statement of Operations - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Statements of Operations [Abstract]
REVENUES	$ 23,703	$ 19,597
OPERATING EXPENSES
Cost of revenues	3,530	994
Advertising	29,764	501,451
Payroll and related expense	1,156,914	907,870
Stock based compensation	222,700	6,924,242
Impairment on COWA advances	360,500
Amortization of software costs	38,549	438,264
Impairment of software costs	196,315	606,714
Other general and administrative expenses	1,460,867	4,524,577
Total operating expenses	3,469,139	13,904,112
LOSS FROM OPERATIONS	(3,445,436)	(13,884,515)
OTHER (EXPENSE)
Interest expense	(4,935,470)	(1,971,329)
Preferred stock issuance costs	(5,585,594)
Derivative liability for authorized shares shortfall	(18,921,537)
Change in fair value of derivative liabilities	(685,415)	(160,597)
Loss on sale of securities	(91,931)
Loss on conversion of convertible debentures	(603,529)
Total Other (Expense)	(30,823,476)	(2,131,926)
Net Loss before Income Taxes	(34,268,912)	(16,016,441)
Provision for Income taxes (benefit)
NET LOSS	(34,268,912)	(16,016,441)
Contingent beneficial conversion feature on preferred A shares	(45,147,093)
Deemed dividend from warrant price protection	(28,933,472)
Deemed dividend from exchange of preferred shares for convertible notes	(1,476,280)
Deemed dividend for issuance of common shares to settle warrant provision	(437,400)
NET LOSS available to common stockholders	$ (110,263,157)	$ (16,016,441)
Net loss per common share - basic and diluted	$ (0.19)	$ (0.10)
Weighted average common shares outstanding - basic and diluted	576,802,421	155,885,213

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Deficit - USD ($)	Preferred Stock B	Preferred Stock C	Common Stock	Common Stock to be Issued	Additional Paid In Capital	Subscriptions Receivable	Accumulated Deficit	Total
Balance at Dec. 31, 2017			$ 112,166	$ 12,573	$ 63,315,749	$ (564,000)	$ (74,252,214)	$ (11,375,726)
Balance, shares at Dec. 31, 2017			112,165,839	12,572,500
Reclassify fair value of derivative liabilities to retained earnings							9,493,307	9,493,307
Issuance of common stock previously to be issued			$ 14,363	$ (14,363)		$ 564,000		564,000
Issuance of common stock previously to be issued, shares			14,362,500	(14,362,500)
Common stock issued in exercise of cashless warrants			$ 7,906		(7,906)
Common stock issued in exercise of cashless warrants, shares			7,906,470
Common shares issued in lieu of interest expense			$ 325		52,158			52,483
Common shares issued in lieu of interest expense, shares			324,881
Common stock shares to be retired in 2018			$ (1,790)	$ 1,790
Common stock shares to be retired in 2018, shares			(1,790,000)	1,790,000
Common stock issued upon conversion of debentures			$ 3,743		632,507			636,250
Common stock issued upon conversion of debentures, shares			3,742,648
Sale of common stock			$ 13,700		2,726,300			2,740,000
Sale of common stock, shares			13,700,000
Common stock issued upon cashless exercise of options			$ 95		(95)
Common stock issued upon cashless exercise of options, shares			95,134
Common stock issued upon exercise of warrants for cash			$ 4,605	$ 80	632,545			637,230
Common stock issued upon exercise of warrants for cash, shares			4,605,000	80,000
Common stock issued for services			$ 13,594		3,494,593			3,508,187
Common stock issued for services, shares			13,594,000
Fair value of warrants repriced due to price protection					160,597			160,597
Fair value of vesting options					2,146,184			2,146,184
Issuance of convertible warrants					617,563			617,563
Net Loss							(16,016,441)	(16,016,441)
Balance at Dec. 31, 2018			$ 168,707	$ 80	73,770,195		(80,775,348)	(6,836,366)
Balance, shares at Dec. 31, 2018			168,706,472	80,000
Issuance of common stock previously to be issued			$ 80	$ (80)
Issuance of common stock previously to be issued, shares			80,000	(80,000)
Issuance of preferred Series A shares in exchange for warrants canceled					(296,746)			(296,746)
Sale of preferred Series B shares and warrants	$ 1				1,407,499			1,407,500
Sale of preferred Series B shares and warrants, shares	1,126
Conversion of preferred Series A shares to common shares			$ 80,000	$ 903,824	2,153,424			3,137,248
Conversion of preferred Series A shares to common shares, shares			80,000,000	903,823,564
Common stock issued as origination shares			$ 1,250		140,083			141,333
Common stock issued as origination shares, shares			1,250,000
Common stock issued upon conversion of convertible notes			$ 109,583	$ 37,100	1,548,619			1,695,302
Common stock issued upon conversion of convertible notes, shares			109,583,224	37,100,000
Warrants exercised for cash			$ 1,555	$ 1,126	170,268			172,949
Warrants exercised for cash, shares			1,555,160	1,126,250
Common stock issued to satisfy a true-up provision			$ 5,553		16,661			22,214
Common stock issued to satisfy a true-up provision, shares			5,553,191
Common Stock issued in settlement of a warrant provision			$ 9,000		428,400		(437,400)
Common Stock issued in settlement of a warrant provision, shares			9,000,000
Common stock issued in exercise of cashless warrants			$ 3,998		(3,998)
Common stock issued in exercise of cashless warrants, shares			3,997,661
Preferred and common shares issued for services		$ 1	$ 2,950	$ 2,550	203,199			208,700
Preferred and common shares issued for services, shares		1,000	2,950,000	2,550,000
Options issued for services					14,000			14,000
Common shares issued in lieu of interest expense			$ 1,591	$ 60	35,365			37,016
Common shares issued in lieu of interest expense, shares			1,591,240	60,000
Deemed dividend related to warrant price protection					28,933,472		(28,933,472)
Contingent beneficial conversion feature on preferred Series A shares					45,147,093		(45,147,093)
Contingent beneficial conversion feature on preferred Series A shares, shares
Deemed dividend resulting from exchange of preferred Series A and B shares for convertible notes					(1,476,280)			(1,476,280)
Deemed dividend resulting from exchange of preferred Series A and B shares for convertible notes, shares
Preferred Series B shares exchanged for convertible notes	$ (1)				(826,883)			(826,884)
Preferred Series B shares exchanged for convertible notes, shares	(1,126)
Common stock issued for services, shares			37,160,000
Net Loss							(34,268,912)	(34,268,912)
Balance at Dec. 31, 2019		$ 1	$ 384,267	$ 944,660	$ 151,364,371		$ (189,562,225)	$ (36,868,926)
Balance, shares at Dec. 31, 2019		1,000	384,266,948	944,659,814

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (34,268,912)	$ (16,016,441)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of derivative liabilities	685,415	160,597
Preferred stock issuance costs	5,585,594
Depreciation and amortization	45,282	443,062
Financing costs		32,500
Impairment on investment	65,000
Impairment loss on software costs	196,315	606,714
Impairment on COWA advances	360,500
Interest and amortization of debt discount	4,716,970	1,839,960
Loss on conversion of convertible notes payable	603,529
Derivative liability for authorized shares shortfall	18,921,537
Loss on sale of investment	91,931
Loss on sale of property and equipment		47,612
Stock based compensation	222,700	5,654,371
Changes in operating assets and liabilities:
Prepaid and other current assets	12,025	2,556
Advances to COWA, net	(360,500)
Advanced settlement		(10,394)
Security deposit	36,000	(2,498)
Accounts payable and accrued expenses	557,360	(298,115)
Accrued payroll and related expenses	732,027	1,116,176
Net cash used in operating activities	(1,797,227)	(6,423,900)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of of property and equipment		(3,996)
Proceeds from Sale of investments	90,981
Purchase of software		(260,565)
Net cash provided by (used in) investing activities	90,981	(264,561)
CASH FLOWS FROM FINANCING ACTIVITIES
Bank overdrafts	13,749
Proceeds from common stock sales		3,304,000
Proceeds from sale of Series B Shares and warrants	1,407,500
Proceeds from exercise of warrants	172,949	637,230
Proceeds from issuance of convertible notes payable	549,000	3,567,500
Proceeds from issuance of non-convertible notes payable	175,000
Repayment of convertible notes payable		(2,160,938)
Repayment of non-convertible notes payable	(45,400)
Repayment of advances	(595,000)	(360,000)
Proceeds from advances	0	528,650
Net cash provided by financing activities	1,677,798	5,516,442
NET DECREASE IN CASH	(28,448)	(1,172,019)
Cash, beginning of period	29,568	1,201,587
Cash, end of period	1,120	29,568
Supplemental disclosures of cash flow information:
Cash paid during period for interest	218,500	131,369
Cash paid during period for taxes
Supplemental disclosure of non-cash investing and financing activities:
Issuance of common stock previously to be issued	80
Issuance of preferred Series A shares in exchange for warrants canceled	296,746
Conversions of preferred Series A shares to common shares	3,137,248
Common stock issued as origination shares	141,333
Common stock issued upon conversion of convertible notes	1,695,302	636,250
Common stock issued in settlement of a warrant provision	437,400
Common stock issued in exercise of cashless warrants	3,998
Common stock issued in lieu of interest expense	37,017	52,483
Deemed dividend related to warrant price protection	28,933,472
Contingent beneficial conversion feature on preferred Series A shares	45,147,093
Deemed dividend resulting from exchange of preferred Series A and Series B shares for convertible notes	1,476,280
Preferred Series B shares exchanged for convertible notes	826,884
Proceeds received from subscriptions receivable		564,000
Derivative liability reclassed to retained earnings		$ 9,493,307

Nature of Operations and Basis

Nature of Operations and Basis of Presentation	12 Months Ended
	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF OPERATIONS AND BASIS OF PRESENTATION	NOTE 1 – NATURE OF OPERATIONS AND BASIS OF PRESENTATION MassRoots, Inc. ("MassRoots" or the "Company") has created a technology platform for the cannabis industry focused on enabling users to share their cannabis content, follow their favorite dispensaries, and stay connected with the legalization movement. The Company was incorporated in the State of Delaware on April 26, 2013. The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"). Our consolidated financial statements include the accounts of DDDigtal, Inc., Odava, Inc., MassRoots Supply Chain, Inc., and MassRoots Blockchain Technologies, Inc., our wholly-owned subsidiaries. All intercompany transactions were eliminated during consolidation.

Going Concern and Management's

Going Concern and Management's Liquidity Plans	12 Months Ended
	Dec. 31, 2019
Going Concern and Management's Liquidity Plans [Abstract]
GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	NOTE 2 – GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS As of December 31, 2019, the Company had cash of $1,120 and working capital deficit (current liabilities in excess of current assets) of $36,868,926. During the year ended December 31, 2019, net cash used by the Company in operating activities was $1,797,227. These conditions raise substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the consolidated financial statements. During the year ended December 31, 2019, the Company received proceeds of $1,407,500, $172,949, $549,000, and $175,000 from the sale of preferred B shares and warrants, exercise of warrants, issuance of convertible notes, and issuance of non-convertible notes, respectively. The Company does not have cash sufficient to fund operations for the next fiscal year. The Company's primary source of operating funds since inception has been cash proceeds from the public and private placements of the Company's securities, including debt securities, and proceeds from the exercise of warrants and options. The Company has experienced net losses and negative cash flows from operations since inception and expects these conditions to continue for the foreseeable future. For the foreseeable future, the Company's ability to continue its operations is dependent upon its ability to obtain additional capital through public or private equity offerings, debt financings or other sources; financing may not be available to the Company on acceptable terms, or at all. The Company's failure to raise capital as and when needed could have a negative impact on its financial condition and its ability to pursue its business strategy, and the Company may be forced to curtail or cease operations. Management's plans with regard to these matters encompass the following actions: 1) obtain funding from new and current investors to alleviate the Company's working capital deficiency and 2) implement a plan to generate sales. The Company's continued existence is dependent upon its ability to translate its user base into sales. However, the outcome of management's plans cannot be determined with any degree of certainty. Accordingly, the accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplates continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business for one year from the date the consolidated financial statements are issued. The carrying amounts of assets and liabilities presented in the consolidated financial statements do not necessarily purport to represent realizable or settlement values. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. In March 2020, the World Health Organization declared COVID-19 a global pandemic. This contagious disease outbreak, which has continued to spread, and any related adverse public health developments, has adversely affected workforces, customers, economies, and financial markets globally, leading to an economic downturn. It has also disrupted the normal operations of many businesses, including ours. It is not possible for us to predict the duration or magnitude of the adverse results of the outbreak of COVID-19 and its effects on our business or results of operations at this time. A health pandemic is a disease outbreak that spreads rapidly and widely by infection and affects many individuals in an area or population at the same time. Customers might avoid public gathering places in the event of a health pandemic, and local, regional or national governments might continue to limit or ban public gatherings to halt or delay the spread of disease. The conditions may impact our clients' and our ability to raise capital.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation The accompanying consolidated financial statements include the accounts of MassRoots, Inc. and its wholly-owned operating subsidiaries. All material intercompany accounts and transactions are eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include stock-based compensation, fair values relating to derivative liabilities, fair value of our payroll tax liabilities, and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates. Fair Value of Financial Instruments The Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") subtopic 825-10, Financial Instruments ("ASC 825-10") requires disclosure of the fair value of certain financial instruments. The carrying value of cash and cash equivalents, accounts payable and accrued liabilities as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments. All other significant financial assets, financial liabilities and equity instruments of the Company are either recognized or disclosed in the financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. The Company follows ASC 825-10, which permits entities to choose to measure many financial instruments and certain other items at fair value. Cash and Cash Equivalents For purposes of the Statements of Cash Flows, the Company considers highly liquid investments with an original maturity of three months or less to be cash equivalents. As of December 31, 2019, and 2018, the Company had no cash equivalents. The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. At December 31, 2019 and 2018, the uninsured balances amounted to $0. Property and Equipment Property and equipment are stated at cost and depreciated using the straight-line method over their estimated useful lives of three to five years. Repair and maintenance costs are expensed as occurred. When retired or otherwise disposed, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition, is reflected in earnings. Accounts Receivable and Allowance for Doubtful Accounts The Company monitors outstanding receivables based on factors surrounding the credit risk of specific customers, historical trends, and other information. The allowance for doubtful accounts is estimated based on an assessment of the Company's ability to collect on customer accounts receivable. There is judgment involved with estimating the allowance for doubtful accounts, and if the financial condition of the Company's customers were to deteriorate, resulting in their inability to make the required payments, the Company may be required to record additional allowances or charges against revenues. The Company writes-off accounts receivable against the allowance when it determines a balance is uncollectible and no longer actively pursues its collection. Revenue Recognition The Company recognizes revenue when services are realized or realizable and earned less estimated future doubtful accounts. The Company's revenues accounted for under ASC Topic 606, Revenue From Contracts With Customers ("ASC 606") generally do not require significant estimates or judgments based on the nature of the Company's revenue streams. The sales prices are generally fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company's contracts do not include multiple performance obligations or material variable consideration. In accordance with ASC 606, the Company recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. MassRoots recognizes revenue in accordance with that core principle by applying the following: (i) Identify the contract(s) with a customer; (ii) Identify the performance obligation in the contract; (iii) Determine the transaction price; (iv) Allocate the transaction price to the performance obligations in the contract; and (v) Recognize revenue when (or as) MassRoots satisfies a performance obligation. The Company primarily generates revenue by charging businesses to advertise on the Company's network. The Company has the ability to target advertisements directly to a client's target audience based on their location and on their mobile devices. In cases where clients sign advertising contracts for an extended period of time, the Company only realizes revenue for services provided during that quarter and defers all other revenue to future periods. Acquisitions and Subsidiaries Subsidiaries are all entities over which MassRoots has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. The existence and effect of potential voting rights that are currently exercisable or convertible are considered when assessing whether MassRoots controls another entity. Subsidiaries are fully consolidated from the date on which control is transferred to MassRoots. The purchase method of accounting is used to account for the acquisition of subsidiaries by MassRoots. The cost of an acquisition is measured as the fair value of the assets transferred as consideration, equity instruments issued and liabilities incurred or assumed at the date of exchange, plus costs directly attributable to the acquisition. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date, irrespective of the extent of any minority interest. The excess of the cost of acquisition over the fair value of the MassRoots' share of the identifiable net assets acquired is recorded as goodwill. If the cost of acquisition is less than the fair value of the net assets of the subsidiary acquired, the difference is recognized directly in the income statement. Investments Investments are accounted for under the cost or the equity method of accounting, as appropriate. The Company accounts for investments in limited partnerships or limited liability corporations, whereby the Company owns a minimum of 5.0% of the investee's outstanding voting stock, under the equity method of accounting. These investments are recorded at the amount of the Company's investment and adjusted each period for the Company's share of the investee's income or loss, and dividends paid. As investments accounted for under the cost method do not have readily determinable fair values, the Company only estimates fair value if there are identified events or changes in circumstances that could have a significant adverse effect on the investment's fair value. Software, Equipment and Leasehold Improvements Software, equipment and leasehold improvements are stated at cost. Depreciation and amortization for software, equipment and leasehold improvements is computed using the straight line method based on the useful lives of the assets (one to five years) or the remaining lease term, if shorter. Any allowance for leasehold improvements received from the landlord for improvements to our facilities is amortized using the straight-line method over the lesser of the remaining lease term or the useful life of the leasehold improvements. Repairs and maintenance costs are expensed as incurred. Advertising The Company follows the policy of charging the costs of advertising to expense as incurred. For the twelve months ended December 31, 2019 and 2018, the Company charged to operations $29,764 and $501,451, respectively, as advertising expense. Stock Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees, non-employees and directors, the fair value of the award is measured on the grant date. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Income Taxes The Company follows ASC subtopic 740-10, Income Taxes ("ASC 740-10") for recording the provision for income taxes. Deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expenses or benefits are based on the changes in the asset or liability during each period. If available evidence suggests that it is more likely than not that some portion or all of the deferred tax assets will not be realized, a valuation allowance is required to reduce the deferred tax assets to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income taxes in the period of change. Deferred income taxes may arise from temporary differences resulting from income and expense items reported for financial accounting and tax purposes in different periods. Convertible Instruments U.S. GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable to generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under ASC 480, "Distinguishing Liabilities From Equity." When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption using the effective interest method. Deemed Dividends and Beneficial Conversion Feature The Company records, when necessary, deemed dividends for: (i) warrant price protection, based on the difference between the fair value of the warrants immediately before and after the repricing (inclusive of any full ratchet provisions), (ii) the exchange of preferred shares for convertible notes, based on the amount of the face value of the convertible notes in excess of the carrying value of the preferred shares, and (iii) the settlement of warrant provisions, based on the fair value of the common shares issued. The Company also records, when necessary, a contingent beneficial conversion resulting from price protection of the conversion price of Series A preferred shares, based on the change in the intrinsic value of the conversion options embedded in the preferred stock. Derivative Financial Instruments The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) provide the Company with a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement) providing that such contracts are indexed to the Company's own stock. The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company's control) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required. The Company's free-standing derivatives consisted of warrants to purchase common stock that were issued in connection with the issuance of debt and the sale of common stock, and of embedded conversion options with convertible debentures. The Company evaluated these derivatives to assess their proper classification in the balance sheet as of December 31, 2019 and 2018 using the applicable classification criteria enumerated under ASC 815, Derivatives and Hedging. The Company determined that certain embedded conversion and/or exercise features did not contain fixed settlement provisions. The convertible debentures contained a conversion feature such that the Company could not ensure it would have adequate authorized shares to meet all possible conversion demands. As such, the Company was required to record the derivatives which do not have fixed settlement provisions as liabilities and mark to market all such derivatives to fair value at the end of each reporting period. The Company also records derivative liabilities for instruments, including convertible notes, preferred stock, and warrants, in which the Company does not have sufficient authorized shares to cover the conversion of these instruments into shares of common stock. Long-Lived Assets The Company reviews its property and equipment and any identifiable intangibles for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The test for impairment is required to be performed by management at least annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted operating cash flow expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell. Intangible assets are stated at cost and reviewed annually to examine any impairments, usually assuming an estimated useful lives of three to five years. When retired or otherwise disposed, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition, is reflected in earnings. Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, "Business Combinations," where the total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price is allocated using the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year and whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. Segment Reporting Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the Chief Executive Officer, or decision-making group, in deciding the method to allocate resources and assess performance. The Company currently has one reportable segment for financial reporting purposes, which represents the Company's core business. Net Earnings (Loss) Per Common Share The Company computes earnings (loss) per share under ASC subtopic 260-10, Earnings Per Share. Net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the "treasury stock" and/or "if converted" methods, as applicable. The computation of basic and diluted income (loss) per share, for the twelve months ended December 31, 2019 and 2018 excludes potentially dilutive securities when their inclusion would be anti-dilutive, or if their exercise prices were greater than the average market price of the common stock during the period. Potentially dilutive securities excluded from the computation of basic and diluted net loss per share are as follows: December 31, December 31, Common stock issuable upon conversion of convertible notes 3,697,833,022 13,146,218 Options to purchase common shares 27,621,765 27,371,765 Warrants to purchase common shares 3,342,376,365 74,910,002 Totals 7,067,831,152 115,427,985 Reclassification Certain reclassifications have been made to the prior years' data to conform to the current year presentation. These reclassifications had no effect on reported income (losses). Recent Accounting Pronouncements FASB Accounting Standards Updates ("ASU") 2017-04 (Topic 350), "Intangibles – Goodwill and Others" FASB ASU 2017-01 (Topic 805), "Business Combinations: Clarifying the Definition of a Business" FASB ASU 2016-02, Leases (Topic 842) FASB issued ASU 2017-11, Earnings Per Share, Distinguishing Liabilities from Equity, and Derivatives and Hedging ("ASU 2017-11") FASB ASU No. 2018-07 (Topic 718), "Compensation – Stock Compensation: Improvements to Nonemployee Share-Based Payment Accounting" – There are other various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to have a material impact on the Company's financial position, results of operations or cash flows.

Investments

Investments	12 Months Ended
	Dec. 31, 2019
Investments, Debt and Equity Securities [Abstract]
INVESTMENTS	NOTE 4 – INVESTMENTS As of December 31, 2019 and 2018, the carrying value of our investments in privately held companies totaled $0 and $247,912, respectively. These investments are accounted for as cost method investments, as we owned less than 20% of the voting securities and do not have the ability to exercise significant influence over operating and financial policies of the entities. During the twelve months ended December 31, 2017, the Company acquired 23,810 shares of Class A common stock of Hightimes Holding Corp. for $100,002, or $4.20 per share. As a result of a forward share split of 1.9308657-for-1 on January 15, 2018, MassRoots owned 45,974 shares of Class A common stock. The acquired Class A common stock were considered non-marketable securities. The Company incurred an impairment of $65,000 on these shares during the twelve months ended December 31, 2019. The Company sold 45,974 shares of Class A common stock for proceeds of $35,000 during the twelve months ended December 31, 2019. On July 13, 2017, the Company purchased an unsecured convertible promissory note in the principal amount of $300,000 from CannaRegs, Ltd, a Colorado limited liability company ("CannaRegs"). The note bears interest at a rate of 5% per annum and matures on December 19, 2019. In the event CannaRegs consummates an equity financing in excess of $2,000,000 prior to the maturity date of the note, the outstanding principal and any accrued and unpaid interest automatically converts into equity securities of the same class or series issued by CannaRegs at the lesser of: a) 90% of the price paid per equity security or b) a price reflecting a valuation cap of $4,500,000. On July 17, 2017, MassRoots converted the note into 430,622 shares of CannaRegs' common stock. In 2018, CannaRegs re-incorporated as a Delaware C corporation under the name Regs Technology, Inc. ("Regs Technology"), keeping the same capitalization structure and business operations. MassRoots valued its holdings at $0 and $147,876 as of December 31, 2019 and 2018, respectively. The Company recorded an impairment expense of $155,336 on its holdings during fiscal year 2018 and recorded a $91,931 loss on the sale of investment during the twelve months ended December 31, 2019. The Company sold its shares of Regs Technology for $55,983 during the twelve months ended December 31, 2019. MassRoots owned less than 1% of Regs Technology's issued and outstanding shares prior to the sale.

Advances to COWA Science Corpor

Advances to COWA Science Corporation	12 Months Ended
	Dec. 31, 2019
Related Party Transactions [Abstract]
ADVANCES TO COWA SCIENCE CORPORATION	NOTE 5 – ADVANCES TO COWA SCIENCE CORPORATION On February 11, 2019, the Company entered into an Agreement and Plan of Merger (the "Merger Agreement") with MassRoots Supply Chain, Inc., a wholly-owned subsidiary of the Company ("Merger Subsidiary"), COWA Science Corporation, a Delaware corporation ("COWA"), and Christopher Alameddin, an individual acting solely in his capacity as a stockholder representative ("Stockholder Representative"). Pursuant to the Merger Agreement, Merger Subsidiary will be merged with and into COWA, whereby the separate corporate existence of Merger Subsidiary will cease and COWA will be the surviving entity (the "Surviving Entity") and will be a wholly-owned subsidiary of the Company (the "Merger"). Upon effectiveness of the Merger (such time, the "Effective Date"), MassRoots will issue 50,000,000 shares of its common stock to the stockholders of COWA, allocated pro-rata based on each stockholder's respective holdings of COWA immediately prior to the Effective Date and each share of the common stock of Merger Subsidiary will be converted into one newly issued, fully paid and non-assessable share of common stock of the Surviving Entity. If (i) within three years after the Effective Date, COWA has generated an aggregate of $2.5 million in revenue, the Company shall issue an aggregate of 25 million shares of common stock to the COWA stockholders; and (ii) within three years after the Effective Date, COWA has generated an aggregate of $7.5 million in revenue (inclusive of the $2.5 million in revenue generated in clause (i)), the Company shall issue an aggregate of 25 million additional shares of common stock to the COWA stockholders. As of December 31, 2019, the Merger had not been effectuated. As of December 31, 2019, MassRoots had advanced $370,500 to COWA for working capital, which is to be repaid on-demand should the Merger not be effectuated. As of December 31, 2019, COWA had repaid $10,000 and the Company wrote off the $360,500 balance of these advances.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	NOTE 6 – PROPERTY AND EQUIPMENT Property and equipment as of December 31, 2019 and December 31, 2018 is summarized as follows: December 31, December 31, Computers $ 6,366 $ 6,366 Office equipment 17,621 17,621 Subtotal 23,987 23,987 Less accumulated depreciation (23,987 ) (17,254 ) Property and equipment, net $ - $ 6,733 Depreciation expense for the years ended December 31, 2019 and 2018 was $6,720 and $4,797, respectively. The Company incurred a loss on the write-off of property and equipment of $0 and $47,612 for fiscal years December 31, 2019 and 2018, respectively.

Software Costs

Software Costs	12 Months Ended
	Dec. 31, 2019
Software Costs [Abstract]
SOFTWARE COSTS	NOTE 7 – SOFTWARE COSTS On December 15, 2016, the Company entered into a merger agreement (the "DDDigtal Merger Agreement") with Whaxy, a wholly-owned subsidiary of the Company, DDDigtal, a Colorado corporation, Zachary Marburger, an individual acting solely in his capacity as stockholder representative, and all of the stockholders of DDDigtal. Pursuant to the DDDigtal Merger Agreement, the parties agreed to merge Whaxy with and into DDDigtal, whereby DDDigtal survived as a wholly-owned subsidiary of MassRoots (the "DDDigtal Merger"). On January 25, 2017, the DDDigtal Merger was completed and became effective upon the filing of certificates of merger with the respective Secretary of State of the States of Delaware and Colorado, in such forms as required by, and executed in accordance with, the relevant provisions of the Delaware General Corporation Law and the Colorado Business Corporation Act. Pursuant to the terms of the DDDigtal Merger Agreement, each share of DDDigtal's common stock was to be exchanged for a number of shares of the Company's common stock (or a fraction thereof), based on an exchange ratio, as ultimately calculated, equal to approximately 5.273-for-1, such that 1 share of the Company's common stock was issued for every 5.273 shares of DDDigtal's common stock. On the effective date of the DDDigtal Merger (the "DDDigtal Effective Date"), the Company issued an aggregate of 2,926,830 shares of the Company's common stock pro rata to all stockholders of DDDigtal in exchange for all of the outstanding shares of DDDigtal's common stock. At the same time, each share of the common stock of Merger Subsidiary was converted into and exchanged for one share of common stock of DDDigtal held by the Company, and all shares of DDDigtal common stock outstanding immediately prior to the DDDigtal Effective Date were automatically cancelled and retired. At the DDDigtal Effective Date, DDDigtal continued as a surviving wholly-owned subsidiary of the Company and Whaxy ceased to exist. In addition, pursuant to the terms of the DDDigtal Merger Agreement, the Company paid cash consideration, in December 2016, of $40,000 to Zachary Marburger and $20,000 to Micah Davidson, as repayment of outstanding debts owed by DDDigtal to such individuals. As a condition to the closing of the DDDigtal Merger, the Company hired Zachary Marburger as its Vice President of Strategy and engaged Micah Davidson as a Senior Software Engineer. As a condition of Mr. Marburger's employment and pursuant to the DDDigtal Merger Agreement, the Company paid Mr. Marburger an additional $40,000 following the one-year anniversary of his constant employment with the Company. Cash (paid in December 2016) $ 60,000 2,926,830 shares of the Company's common stock 2,883,220 Liabilities assumed 40,140 Total purchase price $ 2,983,360 Cash $ 8,672 Accounts receivable 3,583 Property and equipment 3,333 Software 1,253,000 (1) Goodwill 1,714,772 Assets acquired $ 2,983,360 (1) The estimated useful life for software development is assumed at three years. The acquisition was completed in January 2017, however the allocation of proceeds to identifiable assets was recognized during fourth quarter of 2017. During management's annual review of these assets for fiscal year 2018, the remaining value of these assets was written-off due to minimal revenue generated from this software. MassRoots recorded an impairment expense of $415,378 during fiscal year 2018 for these assets, as compared to $1,714,772 during fiscal year 2017, a reduction of $1,299,394. In January 2018, MassRoots entered into a Master Services Agreement with MEV, LLC ("MEV") pursuant to which MEV will assist with the development and servicing of the Company's technology platform, including its mobile applications, business portal and WeedPass. MassRoots has capitalized the billable costs of engineers that were devoted to building the system and developing additional features that enhanced its ability to generate revenue. MassRoots did not capitalize any costs associated with maintenance, user-testing, analysis and planning of the system. The Company has been amortizing these capitalized costs using a straight-line methodology over five years, since July 5, 2018. During fiscal year 2018, MassRoots paid MEV $521,839 with respect to the development and maintenance of its platform, of which MassRoots has capitalized $260,565 in development costs. During fiscal year 2019 and 2018, MassRoots incurred amortization of software costs of $38,549 and $438,264, respectively. During the same period, MassRoots incurred impairment of software costs of $196,315 and $606,714, respectively.

Advances and Non-Convertible No

Advances and Non-Convertible Notes Payable	12 Months Ended
	Dec. 31, 2019
Advances And Non-convertible Notes Payable
ADVANCES AND NON-CONVERTIBLE NOTES PAYABLE	NOTE 8 – ADVANCES AND NON-CONVERTIBLE NOTES PAYABLE During the years ended December 31, 2019 and 2018, the Company received aggregate proceeds from advances of $0 and $528,650 and repaid an aggregate of $595,000 and $360,000, respectively, of advances. The advances were primarily for Simple Agreements for Future Tokens, entered into with eight accredited investors issued pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended, by virtue of Section 4(a)(2) thereof and/or During the years ended December 31, 2019 and 2018, the Company received aggregate proceeds from non-convertible notes of $175,000 and $0 and repaid an aggregate of $45,400 and $0, respectively, of non-convertible notes. The non-convertible notes had maturity dates from March 21, 2019 to September 15, 2019 and have annual interest rates from 0%-20%. As of December 31, 2019 and 2018, the Company owed $165,750 and $26,150 in principal and accrued interest of $158,143 and $10,000, respectively.

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses	12 Months Ended
	Dec. 31, 2019
Accounts Payable And Accrued Expenses
ACCOUNTS PAYABLE AND ACCRUED EXPENSES	NOTE 9 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES As of December 31, 2019, the Company owed accounts payable and accrued expenses of $5,455,063, as compared to $959,688 as of December 31, 2018. These are primarily comprised of payments to vendors, accrued interests on debts, and accrued legal bills.

Accrued Payroll and Related Exp

Accrued Payroll and Related Expenses	12 Months Ended
	Dec. 31, 2019
Accrued Payroll And Related Expenses
ACCRUED PAYROLL AND RELATED EXPENSES	NOTE 10 – ACCRUED PAYROLL AND RELATED EXPENSES The Company is delinquent in filing its payroll taxes, primarily related to stock compensation awards in 2016 and 2017, but also including payroll for 2018 and 2019. At December 31, 2019 and 2018, the Company owes payroll tax liabilities, including interest and penalties, of approximately $3,724,050 and $2,992,023 due to federal and state taxing authorities. The actual liability may be higher or lower due to interest or penalties assessed by federal and state taxing authorities. The Company expects to settle these liabilities by December 31, 2020.

Commitments and Contengiences

Commitments and Contengiences	12 Months Ended
	Dec. 31, 2019
Commitments And Contengiences
COMMITMENTS AND CONTENGIENCES	NOTE 11 – COMMITMENTS AND CONTENGIENCES In the ordinary course of business, the Company is occasionally involved in lawsuits incidental to its business, including litigation related to its convertible debt. Although it is difficult to predict the ultimate outcome of these cases, management believes that any ultimate liability would not have a material adverse effect on the Company's consolidated financial condition or results of operations. However, any unforeseen unfavorable development in any of these cases could have a material adverse effect on the Company's consolidated financial condition, the Company records the potential results of operations or cash flows in the period in which such a determination is made.

Convertible Notes Payable

Convertible Notes Payable	12 Months Ended
	Dec. 31, 2019
Debt Disclosure [Abstract]
CONVERTIBLE NOTES PAYABLE	NOTE 12 – CONVERTIBLE NOTES PAYABLE On August 17, 2017, the Company issued secured convertible notes to certain accredited investors in the aggregate principal amount of $1,045,000. The notes matured on February 18, 2018 and accrued no interest. Net proceeds received by the Company were $942,500 after deduction of legal and other fees. If the Company exercises its right to prepay the notes, the Company shall make payment to the investors in an amount equal to the sum of the then outstanding principal amount of the notes that the Company desires to prepay, multiplied by (a) 1.1, during the first 90 days after the execution of the note, or (b) 1.25, at any point thereafter. The notes are convertible into shares of the Company's common stock at a price per share equal to the lower of (i) $0.75 and (ii) a 25% discount to the price at which the Company next conducts an offering after the issuance date of the notes; provided, however, if any part of the principal amount of the notes remains unpaid at its maturity date, the conversion price will be equal to 65% of the average of the three trading days with the lowest daily weighted average prices of the Company's common stock occurring during the fifteen days prior to the notes' maturity date. In connection with the issuance of the notes, the Company and the investors also entered into a security agreement pursuant to which the notes were secured by all of the assets of the Company currently held or thereafter acquired. In connection with the issuance of the notes, the Company issued five-year warrants to purchase an aggregate of 2,090,000 shares of Company's common stock with an initial exercise price of $0.50 per share. The warrants contain certain anti-dilutive (reset) provisions. From January 1 to January 16, 2018, the Company made payment to the holders of the notes in an aggregate of (i) $510,938 in cash and (ii) pursuant to the right of conversion of the notes, an aggregate of 3,742,648 shares of the Company's common stock. The Company believes that it has completed all of its obligations under the notes and they are retired. On July 5, 2018, the Company issued secured convertible notes to certain accredited investors in the aggregate principal amount of $1,650,000. The notes had a maturity date of January 5, 2019 and accrued no interest. Net proceeds received by the Company were $1,492,500 after deduction of legal and other fees. If the Company exercises its right to prepay the notes, the Company shall make payment to the investors in an amount equal to the sum of the then outstanding principal amount of the notes that the Company desires to prepay, multiplied by (a) 1.1, during the first 90 days after the execution of the note, or (b) 1.25, at any point thereafter. The notes are convertible into shares of the Company's common stock at a price per share equal to the lower of (i) $0.25 and (ii) a 15% discount to the price at which the Company next conducts an offering after the issuance date of the notes; provided, however, if any part of the principal amount of the notes remains unpaid after the maturity date, the conversion price will be equal to 65% of the average of the three trading days with the lowest daily weighted average prices of the Company's common stock occurring during the fifteen days prior to the notes' maturity date. In connection with the issuance of the notes, the Company and the investors also entered into a security agreement pursuant to which the notes are secured by all of the assets of the Company held as of July 5, 2018 and acquired thereafter. The Company also issued five-year warrants to purchase an aggregate of 6,600,000 shares of Company's common stock with an initial exercise price of $0.25. The warrants contain certain anti-dilutive provisions. In December 2018, the Company made payments of an aggregate of $1,762,500 to holders of July 2018 notes In December 2018, the Company issued convertible promissory notes in the aggregate principal amount of $90,000 (including an aggregate original issuance discount of $15,000) maturing June 1, 2019 and bearing interest of 5% per annum. The Company shall have the right to prepay the notes for an amount equal to 130% multiplied by the portion of the Outstanding Balance (as defined in the notes) being prepaid. The investors shall have the right to convert the Outstanding Balance of the note at any time into shares of common stock of the Company at a conversion price of $0.075 per share, subject to adjustment. During the year ended December 31, 2019, the holder converted $90,000 in principal and $9,000 of accrued interest into an aggregate of 6,879,913 shares of common stock. As of December 31, 2019, the aggregate carrying value of the notes was $0. On December 17, 2018, the Company issued a secured convertible promissory note in the principal amount of $2,225,000 (including an original issuance discount of $225,000) which matured on December 17, 2019 and bears interest at a rate of 8% per annum (which shall be increased to 22% upon the occurrence of an event of default). The Company shall have the right to prepay the note for an amount equal to 125% multiplied by the portion of the Outstanding Balance (as defined in the note) being prepaid. In addition, the note is secured by the Security Agreement (as defined below). The investor shall have the right to convert the Outstanding Balance of the note at any time into shares of common stock of the Company at a conversion price of $0.35 per share, subject to adjustment. Commencing on June 17, 2019, the investor shall have the right to redeem all or any portion of the note; provided, however, the investor may not request redemption in an amount that exceeds $350,000 during any single calendar month; provided, further however, upon the occurrence of an event of default, the redemption amount in any calendar month may exceed $350,000. Payments on redemption amounts may be made in cash, by converting the redemption amount into shares of the Company's common stock at a conversion price of the lesser of (a) $0.35 per share, subject to adjustment and (b) the Market Price (as defined in the note), or a combination thereof. Upon the occurrence of an event of default, the investor may accelerate the note pursuant to which the Outstanding Balance will become immediately due and payable in cash at the Mandatory Default Amount (as defined in the note). The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the investor, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company's common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note, which beneficial ownership limitation may be increased by the investor up to, but not exceeding, 9.99%. Pursuant to the terms of the agreement, the Company also entered into a security agreement (the "Security Agreement") on the closing date pursuant to which the Company granted the investor a security interest in the Collateral (as defined in the Security Agreement). On July 16, 2019, the Company received a notice from an investor indicating that events of default had occurred and asserting default penalties of $761,330. During the year ended December 31, 2019, the holder converted $345,000 of principal into an aggregate of 53,522,295 shares of common stock. As of December 31, 2019, the remaining carrying value of the note was $1,880,000, net of debt discount of $0. As of December 31, 2019, accrued interest payable of $1,327,110 was outstanding on the note. From January to June 2019, the Company issued convertible promissory notes in the aggregate principal amount of $389,000 (including aggregate original issuance discount of $39,000) maturing at various dates from July 15, 2019 through June 6, 2020 and bearing interest from 5% to 12% per annum. The Company shall have the right to prepay the notes for an amount equal to 130% multiplied by the portion of the Outstanding Balance (as defined in the notes) being prepaid. The investor shall have the right to convert the Outstanding Balance of the notes at any time into shares of common stock of the Company at a conversion price of $0.075 per share, subject to adjustment. Upon maturity, payment may be made in cash, by converting the redemption amount into shares of the Company's common stock at a conversion price of the lesser of (a) $0.075 per share, subject to adjustment and (b) the Market Price (as defined in the notes), or a combination thereof. Upon the occurrence of an event of default, the investor may accelerate the note pursuant to which the Outstanding Balance will become immediately due and payable in cash at the Mandatory Default Amount (as defined in the notes). The Company is prohibited from effecting a conversion of any note to the extent that, as a result of such conversion, the investor, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company's common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note, which beneficial ownership limitation may be increased by the investor up to, but not exceeding, 9.99%. During the year ended December 31, 2019, the holders converted $31,180 of principal and $8,000 of accrued interest into an aggregate of 10,000,000 shares of common stock. As of December 31, 2019, the remaining carrying value of the notes was $247,746, net of debt discount of $110,074. As of December 31, 2019, accrued interest payable of $456,900 was outstanding on the notes. On November 13, 2019, the Company issued convertible promissory notes in the aggregate principal amount of $108,900, having aggregate original issuance discount of $9,900, resulting in net proceeds of $99,000. The notes mature May 13, 2020 and bear interest of 12% per annum. During the first 180 days the notes are outstanding, the Company shall have the right to prepay the notes for an amount equal to 120% (during the first 90 days) or 135% (during the subsequent 90 days) of the Outstanding Balance (as defined in the notes) being prepaid. The investor shall have the right to convert the Outstanding Balance of the notes at any time into shares of common stock of the Company at a conversion price of $0.01 per share, subject to adjustment. In the event of default, the conversion price shall be 60% of the average of the three lowest closing bid prices of the Company's common stock during the 20 days prior to the Conversion Date. The Company is prohibited from effecting a conversion of any note to the extent that, as a result of such conversion, the investor, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company's common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note, which beneficial ownership limitation may be increased if the Market Capitalization falls below $2,500,000, but not exceeding, 9.99%. As of December 31, 2019, the remaining carrying value of the notes was $14,871, net of debt discount of $94,029. As of December 31, 2019, accrued interest payable of $48,789 was outstanding on the notes. On December 6, 2019, the Company issued convertible promissory notes in the aggregate principal amount of $110,000, having aggregate original issuance discount of $10,000, resulting in net proceeds of $100,000. The notes mature June 6, 2020 and bear interest of 12% per annum. During the first 180 days the notes are outstanding, the Company shall have the right to prepay the notes for an amount equal to 120% (during the first 90 days) or 135% (during the subsequent 90 days) of the Outstanding Balance (as defined in the notes) being prepaid. The investor shall have the right to convert the Outstanding Balance of the notes at any time into shares of common stock of the Company at a conversion price of $0.01 per share, subject to adjustment. In the event of default, the conversion price shall be 60% of the average of the three lowest closing bid prices of the Company's common stock during the 20 days prior to the Conversion Date. The Company is prohibited from effecting a conversion of any note to the extent that, as a result of such conversion, the investor, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company's common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note, which beneficial ownership limitation may be increased if the Market Capitalization (as defined in the notes) falls below $2,500,000, but not exceeding, 9.99%. As of December 31, 2019, the remaining carrying value of the notes was $15,027, net of debt discount of $94,973. As of December 31, 2019, accrued interest payable of $38,904 was outstanding on the notes. In December 2019, the Company and the holders of all of the outstanding Series A and Series B Preferred Shares (the "Preferred Shares") entered into Exchange Agreements whereby 2,800 Series A Preferred Shares outstanding and 1,126 Series B Preferred Shares outstanding were canceled in exchange for the issuance of an aggregate of $3,500,000 and $1,548,250 of convertible promissory notes, respectively. The notes have maturity dates from December 24, 2019 through May 18, 2020 and bear interest of 12% per annum. During the first 180 days the notes are outstanding, the Company shall have the right to prepay the notes for an amount equal to 120% (during the first 90 days) or 135% (during the subsequent 90 days) of the Outstanding Balance (as defined in the notes) being prepaid. The investor shall have the right to convert the Outstanding Balance of the notes at any time into shares of common stock of the Company at a conversion price of $0.005 per share, subject to adjustment. In the event of default, the Outstanding Balance shall immediately increase to 130% of the Outstanding Balance and a penalty of $100 per day shall accrue until the default is remedied. For a period of two years from the issuance date, in the event the Company issues or sells any additional common shares or common stock equivalents at a price less than the Conversion Price (as defined in the notes) then in effect (a "Dilutive Issuance"), the Conversion Price of the notes shall be reduced to the Dilutive Issuance Price and the number of shares issuable upon conversion shall be increased on a full ratchet basis. The Company is prohibited from effecting a conversion of any note to the extent that, as a result of such conversion, the investor, together with its affiliates, would beneficially own more than 9.99% of the number of shares of the Company's common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. During the year ended December 31, 2019, the noteholders converted $185,500 of principal and $300 of accrued interest into an aggregate of 30,669,903 shares of common stock and 37,160,000 shares of common stock to be issued. As of December 31, 2019, the remaining carrying value of the notes was $4,781,395, net of debt discount of $81,355. As of December 31, 2019, accrued interest payable of $1,583,795 was outstanding on the notes. Upon the issuance of certain convertible debentures, the Company determined that the features associated with the embedded conversion option embedded in the debentures, should be accounted for at fair value, as a derivative liability, as the Company cannot determine if a sufficient number of shares would be available to settle all potential future conversion transactions (See Note 13).

Derivative Liabilities and Fair

Derivative Liabilities and Fair Value Measurements	12 Months Ended
	Dec. 31, 2019
Derivative Liabilities and Fair Value Measurements [Abstract]
DERIVATIVE LIABILITIES AND FAIR VALUE MEASUREMENTS	NOTE 13 – DERIVATIVE LIABILITIES AND FAIR VALUE MEASUREMENTS Upon the issuance of certain convertible debentures, warrants, and preferred stock, the Company determined that the features associated with the embedded conversion option embedded in the debentures, should be accounted for at fair value, as a derivative liability, as the Company cannot determine if a sufficient number of shares would be available to settle all potential future conversion transactions. On January 1, 2018 the Company estimated the fair value of the embedded derivatives of $9,493,307 using the Binomial Option Pricing Model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 108.44%, (3) weighted average risk-free interest rate of 1.28% to 2.20%, and (4) expected life of 0.13 to 4.65 years. During the year ended December 31, 2019, upon issuance, the Company estimated the fair value of the embedded derivatives using the Black-Scholes Pricing Model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 110.59% to 119.18%, (3) risk-free interest rate of 1.48% to 2.33%, and (4) expected life of 0.01 to 3.0 years. On December 31, 2019, the Company estimated the fair value of the embedded derivatives of $20,236,870 using the Black-Scholes Pricing Model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 119.18%, (3) risk-free interest rate of 1.48% to 1.62%, and (4) expected life of 0.01 to 3.09 years. The Company adopted the provisions of ASC 825-10. ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of non-performance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value: ● Level 1 – Quoted prices in active markets for identical assets or liabilities. ● Level 2 – Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 – Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities. All items required to be recorded or measured on a recurring basis are based upon Level 3 inputs. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement. The Company recognizes its derivative liabilities as Level 3 and values its derivatives using the methods discussed below. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed are that of volatility and market price of the underlying common stock of the Company. As of December 31, 2019, the Company did not have any derivative instruments that were designated as hedges. Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2019 and 2018: December 31, Quoted Prices Significant Significant Derivative liability $ 20,236,870 $ - $ - $ 20,236,870 December 31, Quoted Prices Significant Significant Derivative liability $ - $ - $ - $ - The following table provides a summary of changes in fair value of the Company's Level 3 financial liabilities for the two years ended December 31, 2019: Balance, January 1, 2018 $ 9,493,307 Cumulative effect adjustment to reclassify fair value of derivative liabilities to retained earnings (9,493,307 ) Balance, December 31, 2018 - Transfers in due to issuance of convertible notes and warrants with embedded conversion and reset provisions 686,059 Transfers out due to conversions of convertible notes and accrued interest into common shares (56,142 ) Derivative liability due to authorized shares shortfall 18,921,538 Mark to market to December 31, 2019 685,415 Balance, December 31, 2019 $ 20,236,870 Loss on change in derivative liabilities for the year ended December 31, 2019 $ (685,415 ) Fluctuations in the Company's stock price are a primary driver for the changes in the derivative valuations during each reporting period. As the stock price increases for each of the related derivative instruments, the value to the holder of the instrument generally increases, therefore increasing the liability on the Company's balance sheet. Additionally, stock price volatility is one of the significant unobservable inputs used in the fair value measurement of each of the Company's derivative instruments. The simulated fair value of these liabilities is sensitive to changes in the Company's expected volatility. Increases in expected volatility would generally result in higher fair value measurement. A 10% change in pricing inputs and changes in volatilities and correlation factors would not result in a material change in our Level 3 fair value.

Stockholders_ Deficit

Stockholders’ Deficit	12 Months Ended
	Dec. 31, 2019
Equity [Abstract]
STOCKHOLDERS’ DEFICIT	NOTE 14 – STOCKHOLDERS' DEFICIT Preferred Stock The Company is authorized to issue 10,000,000 shares of blank check preferred stock, par value $0.001 per share. On July 2, 2019, the Company authorized the issuance of 6,000 Series A preferred stock, par value $0.001 per share. The Series A preferred stock have a $1,250 stated value and are convertible into shares of common stock at $0.05 per share, subject to certain adjustments. The Certificate of Designation for the Series A preferred stock was filed on July 9, 2019. On July 2, 2019 and July 11, 2019, the Company entered into exchange agreements with certain stockholders pursuant to which it exchanged warrants issued in July 2018 to purchase an aggregate of 26,000,000 shares of the Company's common stock for an aggregate of 6,000 shares of Series A Preferred Stock. Accordingly, the fair value of the Series A Preferred Stock of $5,882,340 was recognized, offset by preferred stock issuance costs of $5,585,594, net of a decrease in additional paid in capital of $296,746 for the fair value of the canceled warrants. From July 5, 2019 to September 19, 2019, the Company issued an aggregate of 80,000,000 shares of common stock and 903,823,564 shares of common stock to be issued upon the conversion of 3,200 shares of Series A Preferred Stock. Accordingly, Series A Preferred Stock was decreased by $3,137,248, common stock was increased by the par value of the common shares issued of $80,000, common stock to be issued was increased by the par value of the common shares to be issued $903,824, and additional paid in capital was increased by $2,153,424. On December 3, 2019, the Company retired the remaining 2,800 shares of Series A Preferred Stock in exchange for the issuance of convertible notes (the "Exchange") in the aggregate principal amount of $3,500,000. Accordingly, Series A Preferred Stock was decreased by $2,745,086, additional paid in capital was decreased by $754,914 (stemming from recognition of a deemed dividend recognized immediately prior to the Exchange), and convertible notes payable was increased by $3,500,000. In addition, the derivative liabilities on the Series A Preferred Stock (stemming from the inability to convert caused by the authorized shares shortfall) of $2,012,420 was eliminated with a corresponding decrease in derivative liability for authorized shares shortfall expense. Lastly, derivative liabilities on the newly issued convertible notes (stemming from the inability to convert caused by the authorized shares shortfall) of $54,364 was recognized as an increase in derivative liabilities and a corresponding increase in debt discount on the convertible notes payable. As of December 31, 2019, there were 0 shares of Series A Preferred Stock outstanding. On June 24, 2019, the Company authorized the issuance of 2,000 shares of Series B Preferred Stock, par value $0.001 per share. The Series B Preferred Stock have a $1,250 stated value and are convertible into shares of common stock at $0.05 per share, subjected to certain adjustments. The Certificate of Designation for the Series B Preferred Stock was filed on July 9, 2019. From June 24 to November 16, 2019, the Company issued 1,126 shares of Series B Preferred Stock for proceeds of $1,407,500. From December 3 through December 31, 2019, the Company retired the remaining 1,126 shares of Series B Preferred Stock in exchange for the issuance of convertible notes (the "Exchange") in the aggregate principal amount of $1,548,250. Accordingly, Series B Preferred Stock was decreased by the par value of the preferred shares of $1, additional paid in capital was decreased by $826,883 (for the remaining carrying value of the preferred shares), additional paid in capital was decreased by $721,366 (stemming from recognition of a deemed dividend recognized immediately prior to the Exchange), and convertible notes payable was increased by $1,548,250. In addition, the derivative liabilities on the Series B Preferred Stock (stemming from the inability to convert caused by the authorized shares shortfall) of $776,965 was eliminated with a corresponding decrease in derivative liability for authorized shares shortfall expense. Lastly, derivative liabilities on the newly issued convertible notes (stemming from the inability to convert caused by the authorized shares shortfall) of $85,370 was recognized as an increase in derivative liabilities and a corresponding increase in debt discount on the convertible notes payable. As of December 31, 2019, there were 0 shares of Series B Preferred Stock outstanding. On July 16, 2019, the Company authorized the issuance of 1,000 Series C Preferred Stock, par value $0.001 per share. The 1,000 Series C preferred shares are convertible into 1,000,000 shares of common stock upon the Company listing on a national exchange and other conditions. The Certificate of Designation for the Series C Preferred Stock was filed on July 19, 2019. On October 21, 2019, the Company issued 1,000 Series C Preferred Shares with a value of $10,000 for services rendered. As of December 31, 2019, there were 1,000 shares of Series C Preferred Stock outstanding. Common Stock The Company is authorized to issue 500,000,000 shares of common stock, par value $0.001 per share. As of December 31, 2019, there were 384,266,948 shares of common stock issued and outstanding. The following common stock transactions were recorded during the years ended December 31, 2019 and 2018: During the year ended December 31, 2018, the Company issued an aggregate of 14,362,500 shares of its common stock recorded as to be issued on December 31, 2017. During the year ended December 31, 2018, the Company retired an aggregate of 1,790,000 shares of its common stock recorded as to be retired on December 31, 2017 in exchange for warrants issued in December 2017. During the year ended December 31, 2018, the Company issued an aggregate of 13,594,000 shares of its common stock, having an aggregate fair value of $3,508,187, for services rendered. During the year ended December 31, 2018, the Company issued an aggregate of 95,134 shares for its common stock upon the cashless exercise of outstanding options. During the year ended December 31, 2018, the Company issued an aggregate of 7,906,470 shares of its common stock upon the cashless exercise of outstanding warrants. During the year ended December 31, 2018, the Company issued an aggregate of 3,742,648 shares of its common stock for the settlement of convertible debt with a principal amount of $636,250. During the year ended December 31, 2018, the Company issued an aggregate of 4,605,000 shares of its common stock upon the exercise of outstanding warrants for net proceeds of $637,230. During the year ended December 31, 2018, the Company issued an aggregate of 13,700,000 shares of common stock for cash proceeds of $2,740,000. During the year ended December 31, 2018, the Company received $564,000 recorded as subscription receivable as of December 31, 2017. During the year ended December 31, 2018, the Company issued an aggregate of 324,881 shares in lieu of interest expense $52,483. During the year ended December 31, 2018, the Company received cash proceeds of $6,000 upon the exercise of warrants . During the year ended December 31, 2019, the Company issued an aggregate of 80,000 shares of its common stock recorded as to be issued on December 31, 2018 for a cash warrant exercise. During the year ended December 31, 2019, the Company issued an aggregate of 1,591,240 shares of its common stock as interest expense with a value of $36,830. During the year ended December 31, 2019, the Company issued 5,553,191 shares of its common stock to satisfy a true-up provision with a value of $22,213. During the year ended December 31, 2019, the Company issued an aggregate of 2,950,000 shares of its common stock and recorded an additional 2,550,000 shares as to be issued, having an aggregate fair value of $208,700, for services rendered. During the year ended December 31, 2019, the Company issued an aggregate of 3,997,661 shares of its common stock upon the cashless exercise of outstanding warrants. Accordingly, common stock was increased by the par value of the common shares issued of $3,998 with a corresponding decrease in additional paid in capital. During the year ended December 31, 2019, the Company issued 9,000,000 shares for the settlement of a warrant provision. The fair value of the common shares issued of $437,400 was recognized as a deemed dividend whereby common stock was increased by the par value of the common shares issued of $9,000, additional paid in capital was increased by $428,400 and retained earnings was decreased by $437,400. During the year ended December 31, 2019, the Company issued an aggregate of 1,555,160 shares of its common stock and recorded an additional 1,126,250 shares of common stock as to be issued for the cash exercise of warrants for proceeds of $172,950. During the year ended December 31, 2019, the Company issued an aggregate of 111,174,464 shares of its common stock and 37,160,000 shares of common stock to be issued, having an aggregate fair value of $1,732,318, for the settlement of convertible debt with a principal amount of $1,041,680 and accrued interest of $40,131, which resulted in the elimination of $46,978 of derivative liabilities and an aggregate loss on conversion of convertible notes of $603,529. Accordingly, common stock was increased by the par value of the common shares issued of $111,174, common stock to be issued was increased by the par value of the common shares to be issued of $37,160 and additional paid in capital was increased by $1,583,984. During the year ended December 31, 2019, the Company issued an aggregate of 1,250,000 shares of its common stock as origination shares with a principal amount of $141,333. During the year ended December 31, 2019, the Company issued an aggregate of 80,000,000 shares of common stock and 903,823,564 shares of common stock to be issued upon the conversion of 3,200 shares of Series A Preferred Stock. Accordingly, Series A Preferred Stock was decreased by $3,137,248, common stock was increased by the par value of the common shares issued of $80,000, common stock to be issued was increased by the par value of the common shares to be issued of $903,824 and additional paid in capital was increased by $2,153,424.

Warrants

Warrants	12 Months Ended
	Dec. 31, 2019
Warrants [Abstract]
WARRANTS	NOTE 15 – WARRANTS In January 2018, the Company issued warrants to purchase up to 250,000 shares of the Company's common stock at an exercise price of $0.20 per share to a service provider of the Company. The estimated fair value of $86,483 was charged to current period operations. The fair market value was calculated using the Black Scholes option pricing model, assuming approximately 2.49% risk-free interest, 0% dividend yield, 112.14% volatility, and expected life of five years. In January 2018, in conjunction with the sale of the Company's common stock, the Company granted warrants to purchase up to 13,700,000 shares of the Company's common stock at an exercise price of $0.40 per share, exercisable through January 31, 2023. Due to price protection provisions, the exercise price of the warrants was adjusted to $0.20 on July 26, 2018. In July 2018, the Company issued warrants to purchase up to an aggregate of 6,600,000 shares of the Company's common stock as part of the sale of convertible debentures. In November 2018, MassRoots repriced warrants to purchase common stock covered by the Registration Statement on Form S-1 that was declared effective by the SEC on July 17, 2018 to $0.075 per share. During the year ended December 31, 2019, the Company received $172,950 from cash exercises of warrants to purchase 1,555,160 shares of common stock. During the same period, the Company issued 3,997,661 shares of common stock upon the cashless exercise of warrants to purchase 12,686,249 shares of common stock. On July 2, 2019 and July 11, 2019, the Company entered into exchange agreements with certain stockholders pursuant to which it exchanged warrants issued in July 2018 to purchase an aggregate of 26,000,000 shares of the Company's common stock for an aggregate of 6,000 shares of Series A Preferred Stock. During the year ended December 31, 2019, the Company issued 568,118,340 warrants to purchase shares of common stock at $0.075 per share pursuant to the Series B Preferred Stock offering. During the year ended December 31, 2019, as a result of the Company's Series B Preferred Stock offering, the ratchet provisions in certain warrants were triggered, causing the exercise price to be reset to $0.00224 per share. Accordingly, warrants to purchase 600,551,672 shares of common stock were repriced to a $0.00224 per share exercise price as of December 31, 2019. In addition, warrants to purchase an additional 2,729,734,691 shares of common stock at $0.00224 per share were issued as a result of this ratchet provision. The Company recorded $28,933,472 in deemed dividends as a result of the triggering of price protection provisions in certain outstanding warrants. Accordingly, additional paid in capital was increased by $28,933,472 with a corresponding decrease in the accumulated deficit. Warrants outstanding and exercisable at December 31, 2019 are as follows: Exercise Price Warrants Weighted Avg. Warrants $0.001 – 0.25 3,341,486,363 2.96 3,341,486,363 0.26 – 0.50 565,002 1.42 565,002 0.51 – 0.75 50,000 0.27 50,000 0.76 – 1.00 275,000 0.75 275,000 3,342,376,365 2.96 3,342,376,365 A summary of the warrant activity for the years ended December 31, 2019 and 2018 is as follows: Shares Weighted- Weighted- Aggregate Outstanding at January 1, 2018 35,187,847 $ 0.41 2.30 $ - Grants 60,832,338 0.08 Exercised (20,184,508 ) 0.21 Forfeited/Cancelled (925,675 ) 1.89 Outstanding at December 31, 2018 74,910,002 $ 0.14 3.89 $ - Grants 3,321,040,292 0.00064 Exercised (15,367,659 ) 0.06 Forfeited/Cancelled (38,206,270 ) 0.12 Outstanding at December 31, 2019 3,342,376,365 $ 0.00265 2.96 $ 8,791,956 Exercisable at December 31, 2019 3,342,376,365 $ 0.00265 2.96 $ 8,791,956 The aggregate intrinsic value outstanding stock warrants was $8,791,956, based on warrants with an exercise price less than the Company's stock price of $0.005 as of December 31 2019, which would have been received by the warrant holders had those holders exercised the warrants as of that date.

Stock Options

Stock Options	12 Months Ended
	Dec. 31, 2019
Share-based Payment Arrangement [Abstract]
STOCK OPTIONS	NOTE 16 – STOCK OPTIONS Our stockholders approved our 2014 Equity Incentive Plan in June 2014 (the "2014 Plan"), our 2015 Equity Incentive Plan in December 2015 (the "2015 Plan"), our 2016 Equity Incentive Plan ("2016 Plan") in October 2016, our 2017 Equity Incentive Plan in December 2016 ("2017 Plan" and together with the 2014 Plan, 2015 Plan, 2016 Plan, the "Prior Plans") and our 2018 Equity Incentive Plan in June 2018 (the "2018 Plan", and together with the Prior Plans, the "Plans"). The Prior Plans are identical, except for number of shares reserved for issuance under each. As of December 31, 2018, the Company had granted an aggregate of 60,600,000 securities under the Plans, with 3,900,000 shares available for future issuances. The Plans provide for the grant of incentive stock options to our employees and our parent and subsidiary corporations' employees, and for the grant of non-statutory stock options, stock bonus awards, restricted stock awards, performance stock awards and other forms of stock compensation to our employees, including officers, consultants and directors. The Prior Plans also provide that the grant of performance stock awards may be paid out in cash as determined by the committee administering the Prior Plans. During the year ended December 31, 2018, the Company granted ten-year options outside of our Plans to purchase up to 13,250,000 shares of the Company's common stock. The fair value of $2,146,193, was determined using the Black-Scholes option pricing model, assuming approximately 2.78% - 2.98% risk-free interest, 0% dividend yield, 112.67% - 116.28% volatility, and expected life of ten years and will be charged to operations over the vesting terms of the options. The summary terms of the issuances for the twelve months ended December 31, 2018 are as follows: Exercise Price Number of Vesting Terms $ 0.20 12,000,000 Immediately 0.36 250,000 Immediately 0.40 1,000,000 Immediately During the year ended December 31, 2019, the Company granted ten-year options outside of our Plans to purchase up to 250,000 shares of the Company's common stock for advisory services. The fair value of $14,000, was determined using the Black-Scholes option pricing model, assuming approximately 2.43% risk-free interest, 0% dividend yield, 114% volatility, and expected life of ten years and will be charged to operations over the vesting terms of the options. The summary terms of the issuances for the twelve months ended December 31, 2019 are as follows: Exercise Number of Vesting Terms $ 0.075 250,000 Immediately Stock options outstanding and exercisable on December 31, 2019 are as follows: Exercise Price Number of Remaining Life Number of Options $0.01 – 0.25 13,306,786 8.26 13,306,786 0.26 - 0.50 1,939,631 7.26 1,939,631 0.51 – 0.75 1,820,112 6.68 1,820,112 0.76 - 1.00 9,926,072 6.71 9,926,072 1.01 - 2.00 629,164 6.61 629,164 27,621,765 27,621,765 A summary of the stock option activity for the years ended December 31, 2019 and 2018 is as follows: Shares Weighted- Weighted- Aggregate Outstanding at January 1, 2018 14,378,432 $ 0.76 7.23 $ - Grants 13,250,000 Exercised (256,667 ) Forfeiture/Cancelled - Outstanding at December 31, 2018 27,371,765 $ 0.50 8.42 $ - Grants 250,000 Exercised - Forfeiture/Cancelled - Outstanding at December 31, 2019 27,621,765 $ 0.49 7.49 $ - Exercisable at December 31, 2019 27,621,765 $ 0.49 7.49 $ - The aggregate intrinsic value of outstanding stock options was $0, based on options with an exercise price less than the Company's stock price of $0.005 as of December 31, 2019, which would have been received by the option holders had those option holders exercised their options as of that date. Option valuation models require the input of highly subjective assumptions. The fair value of stock-based payment awards was estimated using the Black-Scholes option pricing model with a volatility figure derived from historical data. The Company accounts for the expected life of options based on the contractual life of options for non-employees. The fair value of all options that were vested as of the year ended December 31, 2019 and 2018 was $14,000 and $459,834, respectively. Unrecognized compensation expense of $0 at December 31, 2019 will be expensed in future periods.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 17 – INCOME TAXES The Tax Cuts and Jobs Acts (the "Act") was enacted on December 22, 2017. The Act reduces the U.S. federal corporate income tax rate from 35% to 21%. ASC 740, "Income Taxes", requires that effects of changes in tax rates to be recognized in the period enacted. Recognizing the late enactment of the Act and complexity of accurately accounting for its impact, the Securities and Exchange Commission in Staff Accounting Bulletin 118 provides guidance that allows registrants to provide a reasonable estimate of the Act in their financial statements and adjust the reported impact in a measurement period not to exceed one year. At December 31, 2019, the Company has available for federal income tax purposes a net operating loss carry forward of approximately $83,792,687, which begin expiring in the year 2033, that may be used to offset future taxable income. The Company has provided a valuation reserve against the full amount of the net operating loss benefit, since in the opinion of management based upon the earnings history of the Company; it is more likely than not that the benefits will not be realized. Due to possible significant changes in the Company's ownership, the future use of its existing net operating losses may be limited. All or portion of the remaining valuation allowance may be reduced in future years based on an assessment of earnings sufficient to fully utilize these potential tax benefits. During the year ended December 31, 2019, the Company has increased the valuation allowance from $14,503,490 to $17,520,829. The Company has adopted the provisions of ASC 740-10-25, which provides recognition criteria and a related measurement model for uncertain tax positions taken or expected to be taken in income tax returns. ASC 740-10-25 requires that a position taken or expected to be taken in a tax return be recognized in the financial statements when it is more likely than not that the position would be sustained upon examination by tax authorities. Tax position that meet the more likely than not threshold are then measured using a probability weighted approach recognizing the largest amount of tax benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company had no tax positions relating to open income tax returns that were considered to be uncertain. Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (the "Code"), provide for annual limitations on the utilization of net operating loss and credit carryforwards if the Company were to undergo an ownership change, as defined in Section 382 of the Code. In general, an ownership change occurs whenever the percentage of the shares of a corporation owned, directly or indirectly, by 5-percent shareholders, as defined in Section 382 of the Code, increases by more than 50 percentage points over the lowest percentage of the shares of such corporation owned, directly or indirectly, by such 5-percent shareholders at any time over the preceding three years. In the event such ownership change occurs, the annual limitation may result in the expiration of the net operating losses prior to full utilization. The Company is required to file income tax returns in the U.S. Federal jurisdiction and in California and Colorado. The Company is no longer subject to income tax examinations by tax authorities for tax years ending before December 31, 2015. The Company's deferred taxes as of December 31, 2019 and 2018 consist of the following: 2019 2018 Non-Current deferred tax asset: (Estimated) Net operating loss carry-forwards $ 17,520,826 $ 14,503,490 Valuation allowance (17,520,826 ) (14,503,490 ) Net non-current deferred tax asset $ - $ - Income Taxes The Company follows ASC 740-10 for recording the provision for income taxes. Deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expenses or benefits are based on the changes in the asset or liability during each period. If available evidence suggests that it is more likely than not that some portion or all of the deferred tax assets will not be realized, a valuation allowance is required to reduce the deferred tax assets to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income taxes in the period of change. Deferred income taxes may arise from temporary differences resulting from income and expense items reported for financial accounting and tax purposes in different periods. Reconciliation between the provision for income taxes and the expected tax benefit using the federal statutory rate of 21% for 2019 and 21% for 2018 is as follows: 2018 2019 US federal statutory income tax rate (21 )% (21 )% State tax – net of benefit (5 )% (5 )% Non-deductible expenses 11 % 11 % Increase in valuation allowance 15 % 15 % Income tax expense - -

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2019
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 18 – RELATED PARTY TRANSACTIONS On October 1, 2019, Isaac Dietrich, the Company's Chief Executive Officer, forfeited warrants received on July 21, 2017. On October 21, 2019, the Company issued 1,000 shares of Series C Preferred Stock, having an aggregate fair value of $10,000, to Isaac Dietrich in recognition of his service to the Company.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2019
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 19 – SUBSEQUENT EVENTS The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. On January 7, 2020, the Company issued and sold a convertible note in the aggregate principal amount of $55,000 (including an aggregate of $5,000 original issuance discount) to an accredited investor. On January 8, 2020, the Company issued 37,160,000 shares of common stock that were recorded as to be issued as of December 31, 2019. On February 24, 2020, the Company terminated the Agreement and Plan of Merger dated February 11, 2019 by and among the Company, Merger Subsidiary, COWA and Christopher Alameddin. On March 5, 2020, the Company issued and sold a convertible note in the aggregate principal amount of $72,600 (including an aggregate of $6,600 original issuance discount) to an accredited investor. On March 17, 2020, the Company issued and sold a convertible note in the aggregate principal amount of $17,600 (including an aggregate of $1,600 original issuance discount) to an accredited investor. On April 17, 2020, the Company issued and sold convertible notes in the aggregate principal amount of $330,000 (including an aggregate of $30,000 original issuance discount) to accredited investors. On April 17, 2020, a shareholder retired 69,000 shares of the Company's common stock. From January 8, 2020 to May 13, 2020, the Company issued 72,368,457 shares of common stock for the settlement of $82,268 in convertible debt and accrued interest. On May 3, 2020, the Company received a loan in the principal amount of $50,000 pursuant to the Paycheck Protection Program ("PPP") of the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act"). The PPP loan matures in May 2022 and bears an interest rate of 1.0% per annum. Payments of principal and interest of any unforgiven balance commence in December 2020. T he Company was unable to meet the original filing deadline of this Annual Report on Form 10-K which was due on March 30, 2020 as a result of circumstances relating to COVID-19. Specifically, as set forth in the Company's Current Report on Form 8-K filed with the SEC on March 30, 2020, as On June 26, 2020, the Company issued and sold a secured promissory note in the principal amount of $60,000 with 10% annual interest. On the two-year anniversary of the issuance of this note, June 26, 2022, all principal and interest becomes due and payable. On July 8, 2020, the Company issued and sold a promissory note in the principal amount of $22,911 with 10% annual interest maturing on December 31, 2020. On July 13, 2020, the Company issued and sold convertible notes in the aggregate principal amount of $110,000 (including an aggregate of $10,000 original issuance discount) to accredited investors which notes mature on January 13, 2021.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of MassRoots, Inc. and its wholly-owned operating subsidiaries. All material intercompany accounts and transactions are eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include stock-based compensation, fair values relating to derivative liabilities and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") subtopic 825-10, Financial Instruments ("ASC 825-10") requires disclosure of the fair value of certain financial instruments. The carrying value of cash and cash equivalents, accounts payable and accrued liabilities as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments. All other significant financial assets, financial liabilities and equity instruments of the Company are either recognized or disclosed in the financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. The Company follows ASC 825-10, which permits entities to choose to measure many financial instruments and certain other items at fair value.
Cash and Cash Equivalents	Cash and Cash Equivalents For purposes of the Statement of Cash Flows, the Company considers highly liquid investments with an original maturity of three months or less to be cash equivalents. As of December 31, 2019, and 2018, the Company had no cash equivalents. The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. At December 31, 2019 and 2018, the uninsured balances amounted to $0.
Property and Equipment	Property and Equipment Property and equipment are stated at cost and depreciated using the straight-line method over their estimated useful lives of three to five years. Repair and maintenance costs are expensed as occurred. When retired or otherwise disposed, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition, is reflected in earnings.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts The Company monitors outstanding receivables based on factors surrounding the credit risk of specific customers, historical trends, and other information. The allowance for doubtful accounts is estimated based on an assessment of the Company's ability to collect on customer accounts receivable. There is judgment involved with estimating the allowance for doubtful accounts, and if the financial condition of the Company's customers were to deteriorate, resulting in their inability to make the required payments, the Company may be required to record additional allowances or charges against revenues. The Company writes-off accounts receivable against the allowance when it determines a balance is uncollectible and no longer actively pursues its collection.
Revenue Recognition	Revenue Recognition The Company recognizes revenue when services are realized or realizable and earned less estimated future doubtful accounts. The Company's revenues accounted for under ASC Topic 606, Revenue From Contracts With Customers ("ASC 606") generally do not require significant estimates or judgments based on the nature of the Company's revenue streams. The sales prices are generally fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company's contracts do not include multiple performance obligations or material variable consideration. In accordance with ASC 606, the Company recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. MassRoots recognizes revenue in accordance with that core principle by applying the following: (i) Identify the contract(s) with a customer; (ii) Identify the performance obligation in the contract; (iii) Determine the transaction price; (iv) Allocate the transaction price to the performance obligations in the contract; and (v) Recognize revenue when (or as) MassRoots satisfies a performance obligation. The Company primarily generates revenue by charging businesses to advertise on the Company's network. The Company has the ability to target advertisements directly to a client's target audience based on their location and on their mobile devices. In cases where clients sign advertising contracts for an extended period of time, the Company only realizes revenue for services provided during that quarter and defers all other revenue to future periods.
Acquisitions and Subsidiaries	Acquisitions and Subsidiaries Subsidiaries are all entities over which MassRoots has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. The existence and effect of potential voting rights that are currently exercisable or convertible are considered when assessing whether MassRoots controls another entity. Subsidiaries are fully consolidated from the date on which control is transferred to MassRoots. The purchase method of accounting is used to account for the acquisition of subsidiaries by MassRoots. The cost of an acquisition is measured as the fair value of the assets transferred as consideration, equity instruments issued and liabilities incurred or assumed at the date of exchange, plus costs directly attributable to the acquisition. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date, irrespective of the extent of any minority interest. The excess of the cost of acquisition over the fair value of the MassRoots' share of the identifiable net assets acquired is recorded as goodwill. If the cost of acquisition is less than the fair value of the net assets of the subsidiary acquired, the difference is recognized directly in the income statement.
Investments	Investments Investments are accounted for under the cost or the equity method of accounting, as appropriate. The Company accounts for investments in limited partnerships or limited liability corporations, whereby the Company owns a minimum of 5.0% of the investee's outstanding voting stock, under the equity method of accounting. These investments are recorded at the amount of the Company's investment and adjusted each period for the Company's share of the investee's income or loss, and dividends paid. As investments accounted for under the cost method do not have readily determinable fair values, the Company only estimates fair value if there are identified events or changes in circumstances that could have a significant adverse effect on the investment's fair value.
Software, Equipment and Leasehold Improvements	Software, Equipment and Leasehold Improvements Software, equipment and leasehold improvements are stated at cost. Depreciation and amortization for software, equipment and leasehold improvements is computed using the straight line method based on the useful lives of the assets (one to five years) or the remaining lease term, if shorter. Any allowance for leasehold improvements received from the landlord for improvements to our facilities is amortized using the straight-line method over the lesser of the remaining lease term or the useful life of the leasehold improvements. Repairs and maintenance costs are expensed as incurred.
Advertising	Advertising The Company follows the policy of charging the costs of advertising to expense as incurred. For the twelve months ended December 31, 2019 and 2018, the Company charged to operations $29,764 and $501,451, respectively, as advertising expense.
Stock Based Compensation	Stock Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees, non-employees and directors, the fair value of the award is measured on the grant date. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period.
Income Taxes	Income Taxes The Company follows ASC subtopic 740-10, Income Taxes ("ASC 740-10") for recording the provision for income taxes. Deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expenses or benefits are based on the changes in the asset or liability during each period. If available evidence suggests that it is more likely than not that some portion or all of the deferred tax assets will not be realized, a valuation allowance is required to reduce the deferred tax assets to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income taxes in the period of change. Deferred income taxes may arise from temporary differences resulting from income and expense items reported for financial accounting and tax purposes in different periods.
Convertible Instruments	Convertible Instruments U.S. GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable to generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under ASC 480, "Distinguishing Liabilities From Equity." When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption using the effective interest method.
Derivative Financial Instruments	Derivative Financial Instruments The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) provide the Company with a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement) providing that such contracts are indexed to the Company's own stock. The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company's control) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required. The Company's free-standing derivatives consisted of warrants to purchase common stock that were issued in connection with the issuance of debt and the sale of common stock, and of embedded conversion options with convertible debentures. The Company evaluated these derivatives to assess their proper classification in the balance sheet as of December 31, 2019 and 2018 using the applicable classification criteria enumerated under ASC 815, Derivatives and Hedging. The Company determined that certain embedded conversion and/or exercise features did not contain fixed settlement provisions. The convertible debentures contained a conversion feature such that the Company could not ensure it would have adequate authorized shares to meet all possible conversion demands. As such, the Company was required to record the derivatives which do not have fixed settlement provisions as liabilities and mark to market all such derivatives to fair value at the end of each reporting period. The Company also records derivative liabilities for instruments, including convertible notes, preferred stock, and warrants, in which the Company does not have sufficient authorized shares to cover the conversion of these instruments into shares of common stock.
Long-Lived Assets	Long-Lived Assets The Company reviews its property and equipment and any identifiable intangibles for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The test for impairment is required to be performed by management at least annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted operating cash flow expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less costs to sell. Intangible assets are stated at cost and reviewed annually to examine any impairments, usually assuming an estimated useful lives of three to five years. When retired or otherwise disposed, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition, is reflected in earnings.
Indefinite Lived Intangibles and Goodwill Assets	Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, "Business Combinations," where the total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price is allocated using the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year and whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable.
Segment Reporting	Segment Reporting Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the Chief Executive Officer, or decision-making group, in deciding the method to allocate resources and assess performance. The Company currently has one reportable segment for financial reporting purposes, which represents the Company's core business.
Net Earnings (Loss) Per Common Share	Net Earnings (Loss) Per Common Share The Company computes earnings (loss) per share under ASC subtopic 260-10, Earnings Per Share. Net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the "treasury stock" and/or "if converted" methods, as applicable. The computation of basic and diluted income (loss) per share, for the twelve months ended December 31, 2019 and 2018 excludes potentially dilutive securities when their inclusion would be anti-dilutive, or if their exercise prices were greater than the average market price of the common stock during the period. Potentially dilutive securities excluded from the computation of basic and diluted net loss per share are as follows: December 31, December 31, Common stock issuable upon conversion of convertible notes 3,697,833,022 13,146,218 Options to purchase common shares 27,621,765 27,371,765 Warrants to purchase common shares 3,342,376,365 74,910,002 Totals 7,067,831,152 115,427,985
Reclassification	Reclassification Certain reclassifications have been made to the prior years' data to conform to the current year presentation. These reclassifications had no effect on reported income (losses).
Recent Accounting Pronouncements	Recent Accounting Pronouncements FASB Accounting Standards Updates ("ASU") 2017-04 (Topic 350), "Intangibles – Goodwill and Others" FASB ASU 2017-01 (Topic 805), "Business Combinations: Clarifying the Definition of a Business" FASB ASU No. 2014-09 (Topic 606), "Revenue from Contracts with Customers" The Company has applied the guidance using the modified retrospective transition method. The adoption of ASU 2014-09 did not have a material impact on the Company's financial position or results of operations but such adoption resulted in additional disclosures regarding the Company's revenue recognition policies. The adoption of ASU 2014-09 did not require material or significant changes to its internal controls over financial reporting. In connection with the application of that guidance and the adoption of ASU 2014-09, the Company has expanded its revenue recognition inquiries and updated its questionnaires to identify matters that would signal variable consideration implications under the new guidance. FASB ASU 2016-02, Leases (Topic 842) FASB issued ASU 2017-11, Earnings Per Share, Distinguishing Liabilities from Equity, and Derivatives and Hedging ("ASU 2017-11") FASB ASU No. 2018-07 (Topic 718), "Compensation – Stock Compensation: Improvements to Nonemployee Share-Based Payment Accounting" – There are other various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to have a material impact on the Company's financial position, results of operations or cash flows.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Schedule of potentially dilutive securities excluded from the computation of basic and diluted net loss per share	December 31, December 31, Common stock issuable upon conversion of convertible notes 3,697,833,022 13,146,218 Options to purchase common shares 27,621,765 27,371,765 Warrants to purchase common shares 3,342,376,365 74,910,002 Totals 7,067,831,152 115,427,985

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Schedule of property and equipment	December 31, December 31, Computers $ 6,366 $ 6,366 Office equipment 17,621 17,621 Subtotal 23,987 23,987 Less accumulated depreciation (23,987 ) (17,254 ) Property and equipment, net $ - $ 6,733

Software Costs (Tables)

Software Costs (Tables)	12 Months Ended
	Dec. 31, 2019
Software Costs [Abstract]
Schedule of software costs	Cash (paid in December 2016) $ 60,000 2,926,830 shares of the Company's common stock 2,883,220 Liabilities assumed 40,140 Total purchase price $ 2,983,360 Cash $ 8,672 Accounts receivable 3,583 Property and equipment 3,333 Software 1,253,000 (1) Goodwill 1,714,772 Assets acquired $ 2,983,360 (1) The estimated useful life for software development is assumed at three years. The acquisition was completed in January 2017, however the allocation of proceeds to identifiable assets was recognized during fourth quarter of 2017. During management's annual review of these assets for fiscal year 2018, the remaining value of these assets was written-off due to minimal revenue generated from this software. MassRoots recorded an impairment expense of $415,378 during fiscal year 2018 for these assets, as compared to $1,714,772 during fiscal year 2017, a reduction of $1,299,394.

Derivative Liabilities and Fa_2

Derivative Liabilities and Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2019
Derivative Liabilities and Fair Value Measurements [Abstract]
Schedule of fair value on a recurring basis in the accompanying financial statements	December 31, Quoted Prices Significant Significant Derivative liability $ 20,236,870 $ - $ - $ 20,236,870 December 31, Quoted Prices Significant Significant Derivative liability $ - $ - $ - $ -
Schedule of changes in fair value of the company's level 3 financial liabilities	Balance, January 1, 2018 $ 9,493,307 Cumulative effect adjustment to reclassify fair value of derivative liabilities to retained earnings (9,493,307 ) Balance, December 31, 2018 - Transfers in due to issuance of convertible notes and warrants with embedded conversion and reset provisions 686,059 Transfers out due to conversions of convertible notes and accrued interest into common shares (56,142 ) Derivative liability due to authorized shares shortfall 18,921,538 Mark to market to December 31, 2019 685,415 Balance, December 31, 2019 $ 20,236,870 Loss on change in derivative liabilities for the year ended December 31, 2019 $ (685,415 )

Warrants (Tables)

Warrants (Tables)	12 Months Ended
	Dec. 31, 2019
Warrants [Abstract]
Schedule of warrants outstanding and exercisable	Exercise Price Warrants Weighted Avg. Warrants $0.001 – 0.25 3,341,486,363 2.96 3,341,486,363 0.26 – 0.50 565,002 1.42 565,002 0.51 – 0.75 50,000 0.27 50,000 0.76 – 1.00 275,000 0.75 275,000 3,342,376,365 2.96 3,342,376,365
Schedule of warrant activity	Shares Weighted- Weighted- Aggregate Outstanding at January 1, 2018 35,187,847 $ 0.41 2.30 $ - Grants 60,832,338 0.08 Exercised (20,184,508 ) 0.21 Forfeited/Cancelled (925,675 ) 1.89 Outstanding at December 31, 2018 74,910,002 $ 0.14 3.89 $ - Grants 3,321,040,292 0.00064 Exercised (15,367,659 ) 0.06 Forfeited/Cancelled (38,206,270 ) 0.12 Outstanding at December 31, 2019 3,342,376,365 $ 0.00265 2.96 $ 8,791,956 Exercisable at December 31, 2019 3,342,376,365 $ 0.00265 2.96 $ 8,791,956

Stock Options (Tables)

Stock Options (Tables)	12 Months Ended
	Dec. 31, 2019
Share-based Payment Arrangement [Abstract]
Schedule of terms of issuances	Exercise Price Number of Vesting Terms $ 0.20 12,000,000 Immediately 0.36 250,000 Immediately 0.40 1,000,000 Immediately Exercise Number of Vesting Terms $ 0.075 250,000 Immediately
Schedule of stock options outstanding and exercisable	Exercise Price Number of Remaining Life Number of Options $0.01 – 0.25 13,306,786 8.26 13,306,786 0.26 - 0.50 1,939,631 7.26 1,939,631 0.51 – 0.75 1,820,112 6.68 1,820,112 0.76 - 1.00 9,926,072 6.71 9,926,072 1.01 - 2.00 629,164 6.61 629,164 27,621,765 27,621,765
Schedule of stock option activity	Shares Weighted- Weighted- Aggregate Outstanding at January 1, 2018 14,378,432 $ 0.76 7.23 $ - Grants 13,250,000 Exercised (256,667 ) Forfeiture/Cancelled - Outstanding at December 31, 2018 27,371,765 $ 0.50 8.42 $ - Grants 250,000 Exercised - Forfeiture/Cancelled - Outstanding at December 31, 2019 27,621,765 $ 0.49 7.49 $ - Exercisable at December 31, 2019 27,621,765 $ 0.49 7.49 $ -

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Schedule of deferred taxes	2019 2018 Non-Current deferred tax asset: (Estimated) Net operating loss carry-forwards $ 17,520,826 $ 14,503,490 Valuation allowance (17,520,826 ) (14,503,490 ) Net non-current deferred tax asset $ - $ -
Schedule of provision for income taxes and the expected tax benefit using the federal statutory rate	2018 2019 US federal statutory income tax rate (21 )% (21 )% State tax – net of benefit (5 )% (5 )% Non-deductible expenses 11 % 11 % Increase in valuation allowance 15 % 15 % Income tax expense - -

Going Concern and Management'_2

Going Concern and Management's Liquidity Plans (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Going Concern and Management's Liquidity Plans (Textual)
Cash	$ 1,120
Working capital deficit	36,868,926
Net cash in operating activities	$ (1,797,227)	$ (6,423,900)
Going concern, description	These conditions raise substantial doubt about the Company’s ability to continue as a going concern for one year from the issuance of the financial statements.
Proceeds from sale of common stock		$ 3,304,000
Proceeds from sale of preferred B shares and warrants	172,949
Proceeds from exercise of warrants	549,000
Proceeds from issuance of convertible notes	175,000
Proceeds from issuance of non-convertible notes payable	$ 175,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Accounting Policies [Abstract]
Common stock issuable upon conversion of convertible notes	3,697,833,022	13,146,218
Options to purchase common shares	27,621,765	27,371,765
Warrants to purchase common shares	3,342,376,365	74,910,002
Totals	7,067,831,152	115,427,985

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details Textual)	12 Months Ended
	Dec. 31, 2019USD ($)Segments / Number	Dec. 31, 2018USD ($)	Jan. 02, 2018USD ($)
Summary of Significant Accounting Policies (Textual)
Advertising	$ 29,764	$ 501,451
Number of reportable segments | Segments / Number	1
Federally insured	$ 250,000
Uninsured amount	$ 0	$ 0
Fair value derivative liabilities			$ 9,493,307
Investee [Member]
Summary of Significant Accounting Policies (Textual)
Ownership percentage	5.00%
Maximum [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment, useful lives	5 years
Minimum [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment, useful lives	3 years

Investments (Details)

Investments (Details) - USD ($)	Jan. 15, 2018	Jul. 17, 2017	Jul. 13, 2017	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Investments (Textual)
Investments				$ 0	$ 247,912
Percentage of voting cost method investment				20.00%
Principal amount of note					390,000
Impairment of investment				$ 65,000
Valuation of impairment investment				$ 35,000
Regs Technology [Member]
Investments (Textual)
Shares issued of common stock				55,983
Class A common stock [Member ]
Investments (Textual)
Shares issued of common stock	45,974			45,974		23,810
Shares issued of common stock, value						$ 100,002
Share price						$ 4.20
Forward stock split, description	Forward share split of 1.9308657-for-1
Cannaregs [Member]
Investments (Textual)
Principal amount of note			$ 300,000
Note bears interest rate, per annum			5.00%
Maturity date of note			Dec. 19, 2019
Financing excess of notes			$ 2,000,000
Description of debt conversion			a) 90% of the price paid per equity security or b) a price reflecting a valuation cap of $4,500,000.
Debt conversion shares issued		430,622
Debt conversion instrument, rate				1.00%
Values of investment holdings				$ 0	147,876
Recorded impairment expense on investment holdings				$ 91,931	$ 155,336

Advances to COWA Science Corp_2

Advances to COWA Science Corporation (Details) - USD ($)	1 Months Ended	12 Months Ended
	Feb. 11, 2019	Dec. 31, 2019	Dec. 31, 2018
Advances to COWA Science Corporation (Textual)
Shares of common stock		384,266,948	168,706,472
Impairment balance		$ (65,000)
Cowa Science Corporation [Member]
Advances to COWA Science Corporation (Textual)
Shares of common stock	50,000,000
Description of revenue	If (i) within three years after the Effective Date, COWA has generated an aggregate of $2.5 million in revenue, the Company shall issue an aggregate of 25 million shares of common stock to the COWA stockholders; and (ii) within three years after the Effective Date, COWA has generated an aggregate of $7.5 million in revenue (inclusive of the $2.5 million in revenue generated in clause (i)), the Company shall issue an aggregate of 25 million additional shares of common stock to the COWA stockholders.
Advanced to COWA		370,500
Repaid by COWA		10,000
Impairment balance		$ 360,500

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Subtotal	$ 23,987	$ 23,987
Less accumulated depreciation	(23,987)	(17,254)
Property and equipment, net		6,733
Computers [Member]
Subtotal	6,366	6,366
Office equipment [Member]
Subtotal	$ 17,621	$ 17,621

Property and Equipment (Detai_2

Property and Equipment (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Property and Equipment (Textual)
Depreciation expense	$ 6,720	$ 4,797
Loss on the write-off of property and equipment	$ 0	$ 47,612

Software Costs (Details)

Software Costs (Details) - Zachary Marburger [Member]	12 Months Ended
	Dec. 31, 2019USD ($)
Cash (paid in December 2016)	$ 60,000
2,926,830 shares of the Company's common stock	2,883,220
Liabilities assumed	40,140
Total purchase price	2,983,360
Cash	8,672
Accounts receivable	3,583
Property and equipment	3,333
Software	1,253,000	[1]
Goodwill	1,714,772
Assets acquired	$ 2,983,360
[1]	The estimated useful life for software development is assumed at three years. The acquisition was completed in January 2017, however the allocation of proceeds to identifiable assets was recognized during fourth quarter of 2017. During management's annual review of these assets for fiscal year 2018, the remaining value of these assets was written-off due to minimal revenue generated from this software. MassRoots recorded an impairment expense of $415,378 during fiscal year 2018 for these assets, as compared to $1,714,772 during fiscal year 2017, a reduction of $1,299,394.

Software Costs (Details Textual

Software Costs (Details Textual) - USD ($)	1 Months Ended		12 Months Ended
	Jan. 25, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Software Costs (Textual)
Development and maintenance, description				MassRoots paid MEV $521,839 with respect to the development and maintenance of its platform, of which MassRoots has capitalized $260,565 in development costs.
Impairment expenses			$ 196,315	$ 606,714
Amortization of software costs			$ 38,549	$ 438,264
Software development [Member]
Software Costs (Textual)
Estimated useful life for software development				3 years
Impairment expenses				$ 415,378	$ 1,714,772
Reduction of impairment expenses				$ 1,299,394
DDDigtal [Member]
Software Costs (Textual)
Shares issued of common stock	2,926,830
Merger Agreement, description	Each share of DDDigtal’s common stock was to be exchanged for a number of shares of the Company’s common stock (or a fraction thereof), based on an exchange ratio, as ultimately calculated, equal to approximately 5.273-for-1, such that 1 share of the Company’s common stock was issued for every 5.273 shares of DDDigtal’s common stock.
Micah Davidson[Member]
Software Costs (Textual)
Company paid cash consideration		$ 20,000
Zachary Marburger [Member]
Software Costs (Textual)
Company paid cash consideration		40,000
Additional amount paid one-year anniversary of his constant employment		$ 40,000

Advances and Non-Convertible _2

Advances and Non-Convertible Notes Payable (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Advances and Non-Convertible Notes Payable (Textual)
Proceeds from advances	$ 0	$ 528,650
Repayment of advances	(595,000)	(360,000)
Advances	337,500	932,500
Accrued interest	10,500	0
Proceeds from issuance of non-convertible notes payable	175,000
Repayments of non-convertible notes	$ 45,400	0
Nnon-convertible notes, description	The non-convertible notes had maturity dates from March 21, 2019 to September 15, 2019 and have annual interest rates from 0%-20%.
Non-convertible notes payable	$ 165,750	26,150
Accrued interest of non convertible note payable	$ 158,143	$ 10,000

Accounts Payable and Accrued _2

Accounts Payable and Accrued Expenses (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Accounts Payable and Accrued Expenses (Textual)
Accounts payable and accrued expenses	$ 5,455,063	$ 959,668

Accrued Payroll and Related E_2

Accrued Payroll and Related Expenses (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Accrued Payroll and Related Expenses (Textual)
Accrued payroll and related expenses	$ 3,724,050	$ 2,992,023

Convertible Notes Payable (Deta

Convertible Notes Payable (Details) - USD ($)	Dec. 06, 2019	Nov. 13, 2019	Jul. 16, 2019	Dec. 17, 2018	Jul. 05, 2018	Jan. 16, 2018	Jan. 02, 2018	Aug. 17, 2017	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2019
Aggregate principal amount										$ 390,000
Issued upon conversion of value									$ 1,695,302
Aggregate carrying value									0
Default penalties expenses occurred			$ 761,330
Accrued interest payable									158,143	10,000
Debt discount									$ 380,431	209,898
Exchange Agreements [Member]
Description of debt conversion									The Company and the holders of all of the outstanding Series A and Series B Preferred Shares (the “Preferred Shares”) entered into Exchange Agreements whereby 2,800 Series A Preferred Shares outstanding and 1,126 Series B Preferred Shares outstanding were canceled in exchange for the issuance of an aggregate of $3,500,000 and $1,548,250 of convertible promissory notes, respectively. The notes have maturity dates from December 24, 2019 through May 18, 2020 and bear interest of 12% per annum. During the first 180 days the notes are outstanding, the Company shall have the right to prepay the notes for an amount equal to 120% (during the first 90 days) or 135% (during the subsequent 90 days) of the Outstanding Balance (as defined in the notes) being prepaid. The investor shall have the right to convert the Outstanding Balance of the notes at any time into shares of common stock of the Company at a conversion price of $0.005 per share, subject to adjustment. In the event of default, the Outstanding Balance shall immediately increase to 130% of the Outstanding Balance and a penalty of $100 per day shall accrue until the default is remedied.
Convertible Debt [Member]
Issued upon conversion of value									$ 345,000
Issued upon conversion of shares									53,522,295
Accrued interest payable									$ 456,900
Debt discount		$ 94,029							$ 110,074
Secured Convertible Promissory Note [Member]
Aggregate principal amount		$ 108,900		$ 2,225,000						$ 90,000	$ 389,000
Notes mature date				Dec. 17, 2019						Jun. 30, 2019
Notes maturity, Description		The notes mature May 13, 2020 and bear interest of 12% per annum.							Maturing at various dates from July 15, 2019 through June 6, 2020.
Net proceeds received amount		$ 99,000
Description of debt conversion	the Company issued convertible promissory notes in the aggregate principal amount of $110,000, having aggregate original issuance discount of $10,000, resulting in net proceeds of $100,000. The notes mature June 6, 2020 and bear interest of 12% per annum. During the first 180 days the notes are outstanding, the Company shall have the right to prepay the notes for an amount equal to 120% (during the first 90 days) or 135% (during the subsequent 90 days) of the Outstanding Balance (as defined in the notes) being prepaid. The investor shall have the right to convert the Outstanding Balance of the notes at any time into shares of common stock of the Company at a conversion price of $0.01 per share, subject to adjustment. In the event of default, the conversion price shall be 60% of the average of the three lowest closing bid prices of the Company’s common stock during the 20 days prior to the Conversion Date. The Company is prohibited from effecting a conversion of any note to the extent that, as a result of such conversion, the investor, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note, which beneficial ownership limitation may be increased if the Market Capitalization (as defined in the notes) falls below $2,500,000, but not exceeding, 9.99%.	During the first 180 days the notes are outstanding, the Company shall have the right to prepay the notes for an amount equal to 120% (during the first 90 days) or 135% (during the subsequent 90 days) of the Outstanding Balance (as defined in the notes) being prepaid. The investor shall have the right to convert the Outstanding Balance of the notes at any time into shares of common stock of the Company at a conversion price of $0.01 per share, subject to adjustment. In the event of default, the conversion price shall be 60% of the average of the three lowest closing bid prices of the Company’s common stock during the 20 days prior to the Conversion Date. The Company is prohibited from effecting a conversion of any note to the extent that, as a result of such conversion, the investor, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note, which beneficial ownership limitation may be increased if the Market Capitalization falls below $2,500,000, but not exceeding, 9.99%.		The Company shall have the right to prepay the note for an amount equal to 125% multiplied by the portion of the Outstanding Balance (as defined in the note) being prepaid. In addition, the note is secured by the Security Agreement (as defined below). The investor shall have the right to convert the Outstanding Balance of the note at any time into shares of common stock of the Company at a conversion price of $0.35 per share, subject to adjustment. Commencing on June 17, 2019, the investor shall have the right to redeem all or any portion of the note; provided, however, the investor may not request redemption in an amount that exceeds $350,000 during any single calendar month; provided, further however, upon the occurrence of an event of default, the redemption amount in any calendar month may exceed $350,000. Payments on redemption amounts may be made in cash, by converting the redemption amount into shares of the Company’s common stock at a conversion price of the lesser of (a) $0.35 per share, subject to adjustment and (b) the Market Price (as defined in the note), or a combination thereof. Upon the occurrence of an event of default, the investor may accelerate the note pursuant to which the Outstanding Balance will become immediately due and payable in cash at the Mandatory Default Amount (as defined in the note). The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the investor, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note, which beneficial ownership limitation may be increased by the investor up to, but not exceeding, 9.99%.					The Company shall have the right to prepay the notes for an amount equal to 130% multiplied by the portion of the Outstanding Balance (as defined in the notes) being prepaid. The investor shall have the right to convert the Outstanding Balance of the notes at any time into shares of common stock of the Company at a conversion price of $0.075 per share, subject to adjustment. Upon maturity, payment may be made in cash, by converting the redemption amount into shares of the Company’s common stock at a conversion price of the lesser of (a) $0.075 per share, subject to adjustment and (b) the Market Price (as defined in the notes), or a combination thereof. Upon the occurrence of an event of default, the investor may accelerate the note pursuant to which the Outstanding Balance will become immediately due and payable in cash at the Mandatory Default Amount (as defined in the notes). The Company is prohibited from effecting a conversion of any note to the extent that, as a result of such conversion, the investor, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note, which beneficial ownership limitation may be increased by the investor up to, but not exceeding, 9.99%.	The Company shall have the right to prepay the notes for an amount equal to 130% multiplied by the portion of the Outstanding Balance (as defined in the notes) being prepaid. The investors shall have the right to convert the Outstanding Balance of the note at any time into shares of common stock of the Company at a conversion price of $0.075 per share, subject to adjustment.
Interest on debenture				8.00%						5.00%
Debt increased percentage				22.00%
Debt instrument remaining carrying value	$ 15,027	$ 14,871							$ 247,746	$ 0
Accrued interest payable	38,904								94,029
Debt discount	$ 94,973	$ 9,900		$ 225,000						15,000	$ 39,000
Convertible Promissory Notes One [Member]
Debt instrument remaining carrying value									4,781,395
Accrued interest payable									1,583,795
Debt discount									81,355
Security Agreement [Member]
Debt instrument remaining carrying value									1,880,000
Accrued interest payable									1,327,110
Debt discount									$ 0
Investor [Member]
Aggregate principal amount					$ 1,650,000			$ 1,045,000
Notes mature date					Jan. 5, 2019			Feb. 18, 2018
Net proceeds received amount					$ 1,492,500			$ 942,500
Description of debt conversion					The Company shall make payment to the investors in an amount equal to the sum of the then outstanding principal amount of the notes that the Company desires to prepay, multiplied by (a) 1.1, during the first 90 days after the execution of the note, or (b) 1.25, at any point thereafter. The notes are convertible into shares of the Company’s common stock at a price per share equal to the lower of (i) $0.25 and (ii) a 15% discount to the price at which the Company next conducts an offering after the issuance date of the notes; provided, however, if any part of the principal amount of the notes remains unpaid after the maturity date, the conversion price will be equal to 65% of the average of the three trading days with the lowest daily weighted average prices of the Company’s common stock occurring during the fifteen days prior to the notes’ maturity date.			The Company shall make payment to the investors in an amount equal to the sum of the then outstanding principal amount of the notes that the Company desires to prepay, multiplied by (a) 1.1, during the first 90 days after the execution of the note, or (b) 1.25, at any point thereafter. The notes are convertible into shares of the Company’s common stock at a price per share equal to the lower of (i) $0.75 and (ii) a 25% discount to the price at which the Company next conducts an offering after the issuance date of the notes; provided, however, if any part of the principal amount of the notes remains unpaid at its maturity date, the conversion price will be equal to 65% of the average of the three trading days with the lowest daily weighted average prices of the Company’s common stock occurring during the fifteen days prior to the notes’ maturity date.
Warrants to purchase					6,600,000			2,090,000
Initial exercise price					$ 0.25			$ 0.50
Warrants term					5 years			5 years
Investor [Member] | Exchange Agreements [Member]
Ownership shares, percentage									9.99%
Minimum [Member]
Fair value assumptions weighted average risk-free interest rate									1.48%
Fair value assumptions expected life									4 days
Minimum [Member] | Secured Convertible Promissory Note [Member]
Interest on debenture									5.00%
Maximum [Member]
Fair value assumptions weighted average risk-free interest rate									1.62%
Fair value assumptions expected life									3 years
Maximum [Member] | Secured Convertible Promissory Note [Member]
Interest on debenture									12.00%
At the Date of Inception [Member]
Estimated fair value of embedded derivatives							$ 9,493,307		$ 20,236,870
Fair value assumptions dividend yield							0.00%		0.00%
Fair value assumptions expected volatility							108.44%		119.18%
At the Date of Inception [Member] | Minimum [Member]
Fair value assumptions expected volatility									110.59%
Fair value assumptions weighted average risk-free interest rate							1.28%		1.48%
Fair value assumptions expected life							1 month 16 days		4 days
At the Date of Inception [Member] | Maximum [Member]
Fair value assumptions expected volatility									11918.00%
Fair value assumptions weighted average risk-free interest rate							2.20%		2.33%
Fair value assumptions expected life							4 years 7 months 24 days		3 years
Holders [Member]
Company paid cash consideration						$ 510,938				1,762,500
Issued upon conversion of value									$ 390,000
Debt conversion value									$ 31,180
Issued upon conversion of shares									10,102,353
Debt converted into common stock shares						3,742,648			11,000,000
Issued upon conversion of interest									$ 8,000	$ 22,831
Leaving balance									0
Holders [Member] | Exchange Agreements [Member]
Debt conversion value									$ 185,500
Debt converted into common stock shares									30,669,903
Debt converted into common stock shares									37,160,000
Accrued interest payable									$ 300
Holders [Member] | Secured Convertible Promissory Note [Member]
Issued upon conversion of value									$ 90,000
Issued upon conversion of shares									6,879,913
Issued upon conversion of interest									$ 9,000

Advances and Notes Payable (Det

Advances and Notes Payable (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Advances and Notes Payable [Abstract]
Advances	$ 337,500	$ 932,500
Notes payable	$ 178,500
Description of notes payable agreement	The notes payable agreements not convertible into common stock had maturity dates from March 21, 2019 to September 15, 2019, carried a collective $26,000 in original issuance discounts, have annual interest rates from 0%-20% annually, and have incurred $60,661 in default penalties as of September 30, 2019.

Derivative Liabilities and Fa_3

Derivative Liabilities and Fair Value Measurements (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Derivative liability	$ 20,236,870
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Derivative liability
Significant Other Observable Inputs (Level 2) [Member]
Derivative liability
Significant Unobservable Inputs (Level 3) [Member]
Derivative liability	$ 20,236,870

Derivative Liabilities and Fa_4

Derivative Liabilities and Fair Value Measurements (Details 1)	12 Months Ended
	Dec. 31, 2019USD ($)
Derivative Liabilities and Fair Value Measurements [Abstract]
Balance, January 1, 2018	$ 9,493,307
Cumulative effect adjustment to reclassify fair value of derivative liabilities to retained earnings	(9,493,307)
Balance, December 31, 2018
Transfers in due to issuance of convertible notes and warrants with embedded conversion and reset provisions	686,059
Transfers out due to conversions of convertible notes and accrued interest into common shares	(56,142)
Derivative liability due to authorized shares shortfall	18,921,538
Mark to market to December 31, 2019	685,415
Balance, December 31, 2019	20,236,870
Loss on change in derivative liabilities for the year ended December 31, 2019	$ (685,415)

Derivative Liabilities and Fa_5

Derivative Liabilities and Fair Value Measurements (Details Textual) - USD ($)	1 Months Ended	12 Months Ended
	Jan. 02, 2018	Dec. 31, 2019
Derivative Liabilities and Fair Value Measurements (Textual)
Fair value fluctuations, percentage		10.00%
Minimum [Member]
Derivative Liabilities and Fair Value Measurements (Textual)
Fair value assumptions weighted average risk-free interest rate		1.48%
Fair value assumptions expected life		4 days
Maximum [Member]
Derivative Liabilities and Fair Value Measurements (Textual)
Fair value assumptions weighted average risk-free interest rate		1.62%
Fair value assumptions expected life		3 years
At the Date of Inception [Member]
Derivative Liabilities and Fair Value Measurements (Textual)
Estimated fair value of embedded derivatives	$ 9,493,307	$ 20,236,870
Fair value assumptions dividend yield	0.00%	0.00%
Fair value assumptions expected volatility	108.44%	119.18%
At the Date of Inception [Member] | Minimum [Member]
Derivative Liabilities and Fair Value Measurements (Textual)
Fair value assumptions expected volatility		110.59%
Fair value assumptions weighted average risk-free interest rate	1.28%	1.48%
Fair value assumptions expected life	1 month 16 days	4 days
At the Date of Inception [Member] | Maximum [Member]
Derivative Liabilities and Fair Value Measurements (Textual)
Fair value assumptions expected volatility		11918.00%
Fair value assumptions weighted average risk-free interest rate	2.20%	2.33%
Fair value assumptions expected life	4 years 7 months 24 days	3 years

Stockholders_ Deficit (Details)

Stockholders’ Deficit (Details) - USD ($)	Dec. 03, 2019	Dec. 03, 2019	Oct. 21, 2019	Jul. 11, 2019	Jul. 31, 2019	Jul. 31, 2018	Jan. 31, 2018	Sep. 30, 2019	Nov. 16, 2019	Dec. 31, 2019	Dec. 31, 2018	Jul. 16, 2019	Jul. 08, 2019	Jun. 24, 2019
Common stock, par value										$ 0.001	$ 0.001
Common stock, shares authorized										500,000,000	500,000,000
Common stock, shares issued										384,266,948	168,706,472
Common stock, shares outstanding										384,266,948	168,706,472
Common stock issued to satisfy a true-up provision										$ 22,214
Proceeds form issuance of common stock											$ 3,304,000
Shares of common stock for services, value											3,508,187
Common stock issued in lieu of interest expense										37,017	52,483
Common stock issued as origination shares with principal amount										141,333
Proceeds received from subscriptions receivable											$ 564,000
Fair value of the common shares issued										437,400
Additional paid in capital										428,400
Decreased of retained earnings										437,400
Aggregate fair value										1,732,318
Common shares issued amount										$ 111,174
Common stock description										The Company issued an aggregate of 80,000,000 shares of common stock and 903,823,564 shares of common stock to be issued upon the conversion of 3,200 shares of Series A Preferred Stock. Accordingly, Preferred stock – Series A was decreased by $3,137,248, common stock was increased by the par value of the common shares issued of $80,000, common stock to be issued was increased by the par value of the common shares to be issued $903,824, and additional paid in capital was increased by $2,153,424.
Decreased by additional paid in capital	$ 754,914	$ 754,914								$ 721,366
Increased by convertible notes payable	3,500,000	3,500,000								$ 1,548,250
Increase in derivative liabilities	$ 54,364	54,364
Stock Options [Member]
Common shares issued upon cashless exercise of common stock outstanding, shares											95,134
Series A Preferred Stock [Member]
Blank check preferred stock, shares authorized										6,000	6,000
Blank check preferred stock, par value										$ 0.001	$ 0.001
Blank check preferred stock, shares issued										0	0
Blank check preferred stock, shares outstanding										0	0
Preferred stock shares retired	2,800
Convertible debt principal amount	$ 3,500,000
Decreased of Preferred stock		2,745,086
Decreased in derivative liability	$ 2,012,420	$ 2,012,420
Series B Preferred Stock Offering [Member]
Warrants to purchase shares of common stock										568,118,340
Series C Preferred Shares [Member]
Blank check preferred stock, shares authorized										1,000	1,000
Blank check preferred stock, par value										$ 0.001	$ 0.001
Blank check preferred stock, shares issued			1,000							0	0
Preferred stock of services rendered			$ 10,000
Blank check preferred stock, shares outstanding										0	0
Series A Convertible Preferred Stock [Member]
Blank check preferred stock, shares outstanding	0	0
Series C Convertible Preferred Stock [Member]
Blank check preferred stock, shares outstanding										1,000
Series B Preferred Shares [Member]
Blank check preferred stock, shares authorized										2,000	2,000
Blank check preferred stock, par value										$ 0.001	$ 0.001
Blank check preferred stock, shares issued										0	0
Blank check preferred stock, shares outstanding										0	0
Series B Convertible Preferred Stock [Member]
Blank check preferred stock, shares outstanding										0
Warrant [Member]
Aggregate of common stock issued											1,555,160
Additional to be issued											1,126,250
Common shares issued upon cashless exercise of common stock outstanding, shares											7,906,470
Cash exercise of warrants for proceeds											$ 6,000
Warrants to purchase shares of common stock					26,000,000	26,000,000	250,000			1,555,160
Issued of settlement warrant										9,000,000
Warrant [Member] | Series B Preferred Stock Offering [Member]
Warrants to purchase shares of common stock										600,551,672
Preferred Stock [Member]
Blank check preferred stock, shares authorized										10,000,000
Blank check preferred stock, par value										$ 0.001
Decreased by additional paid in capital										$ 826,883
Preferred Stock [Member] | Series A Preferred Stock [Member]
Blank check preferred stock, shares authorized													6,000
Blank check preferred stock, par value													$ 0.001
Blank check preferred stock, shares issued				6,000
Proceeds form issuance of preferred stock				$ 5,585,594
Convertible shares of common stock													$ 1,250
Per share price													$ 0.05
Fair value of the preferred stock issued				5,882,340
Decreased by additional paid in capital				$ 296,746
Preferred Stock [Member] | Series B Preferred Stock Offering [Member]
Blank check preferred stock, shares authorized														2,000
Blank check preferred stock, par value														$ 0.001
Blank check preferred stock, shares issued									1,126
Proceeds form issuance of preferred stock									$ 1,407,500
Convertible shares of common stock														$ 1,250
Per share price														$ 0.05
Preferred Stock [Member] | Series C Preferred Shares [Member]
Blank check preferred stock, shares authorized												1,000
Blank check preferred stock, par value												$ 0.001
Convertible shares of common stock												$ 1,250
Per share price												$ 0.005
Preferred Stock [Member] | Series B Preferred Shares [Member]
Preferred stock shares retired										1,126
Convertible debt principal amount										$ 1,548,250
Decreased in derivative liability										776,965
Increase in derivative liabilities										$ 85,370
Decreased preferred stock, par value										1
Common Stock
Common stock, par value										$ 0.001
Common stock, shares authorized										500,000,000
Common stock, shares issued										384,266,948	80,000
Common stock, shares outstanding										384,266,948
Aggregate of common stock issued										1,591,240	13,594,000
Aggregate of common stock shares retired											1,790,000
Shares of common stock issued										5,553,191	13,700,000
Common stock to be issued interest expense										$ 36,830	$ 14,362,500
Common stock issued to satisfy a true-up provision										$ 5,553
Shares of common stock for services										37,160,000	13,594,000
Proceeds form issuance of common stock											$ 2,740,000
Additional to be issued										2,550,000
Shares of common stock for services, value											$ 13,594
Common shares issued upon cashless exercise of common stock outstanding, shares										3,997,661
Common shares issued upon exercise of common stock outstanding warrant											4,605,000
Common stock issued in settlement of convertible debt, shares										111,174,464	3,742,648
Convertible debt principal amount										$ 1,041,680	$ 636,250
Additional common stock issued											324,881
Common stock issued in lieu of interest expense											$ 52,483
Cash exercise of warrants for proceeds										$ 172,950	637,230
Common stock issued as origination shares, shares										1,250,000
Common stock issued as origination shares with principal amount										$ 1,250
Shares of common stock issued stock upon the conversion of Series A Preferred Stock								80,000,000		80,000,000
Warrants to purchase shares of common stock						6,600,000	13,700,000			3,997,661
Proceeds received from subscriptions receivable											$ 564,000
Shares of common stock underlying the warrants											80,000
Accrued interest										$ 40,131
Derivative liabilities										46,978
Aggregate loss on conversion										603,529
Fair value of the common shares issued										37,160
Additional paid in capital										$ 1,583,984
Common Stock | Series A Preferred Stock [Member]
Aggregate of common stock issued										2,950,000
Shares of common stock issued stock upon the conversion of Series A Preferred Stock								903,823,564
Common stock issuable upon conversion of preferred stock								3,200		3,200

Warrants (Details)

Warrants (Details) - Warrants [Member]	12 Months Ended
	Dec. 31, 2019$ / sharesshares
Warrants Outstanding	3,342,376,365
Weighted Avg. Remaining Life	2 years 11 months 15 days
Warrants Exercisable	3,342,376,365
0.001 – 0.25 [Member]
Exercise Price, Minimum | $ / shares	$ 0.001
Exercise Price, Maximum | $ / shares	$ 0.25
Warrants Outstanding	3,341,486,363
Weighted Avg. Remaining Life	2 years 11 months 15 days
Warrants Exercisable	3,341,486,363
0.26 - 0.50 [Member]
Exercise Price, Minimum | $ / shares	$ 0.26
Exercise Price, Maximum | $ / shares	$ 0.50
Warrants Outstanding	565,002
Weighted Avg. Remaining Life	1 year 5 months 1 day
Warrants Exercisable	565,002
0.51 - 0.75 [Member]
Exercise Price, Minimum | $ / shares	$ 0.51
Exercise Price, Maximum | $ / shares	$ 0.75
Warrants Outstanding	50,000
Weighted Avg. Remaining Life	3 months 8 days
Warrants Exercisable	50,000
0.76 - 1.00 [Member]
Exercise Price, Minimum | $ / shares	$ 0.76
Exercise Price, Maximum | $ / shares	$ 1
Warrants Outstanding	275,000
Weighted Avg. Remaining Life	9 months
Warrants Exercisable	275,000

Warrants (Details 1)

Warrants (Details 1) - Warrant Activity [Member] - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Shares, Outstanding	74,910,002	35,187,847
Shares, Grants	3,321,040,292	60,832,338
Shares, Exercised	(15,367,659)	(20,184,508)
Shares, Forfeited/Cancelled	(38,206,270)	(925,675)
Shares, Outstanding	3,342,376,365	74,910,002
Shares, Exercisable	3,342,376,365
Weighted-Average Exercise Price, Outstanding	$ 0.14	$ 0.41
Weighted-Average Exercise Price, Grants	0.00064	0.08
Weighted-Average Exercise Price, Exercised	0.06	0.21
Weighted-Average Exercise Price, Forfeited/Cancelled	0.12	1.89
Weighted-Average Exercise Price, Outstanding	0.00265	$ 0.14
Weighted-Average Exercise Price, Exercisable	$ 0.00265
Weighted-Average Remaining Contractual Term, Outstanding	3 years 10 months 21 days	2 years 3 months 19 days
Weighted-Average Remaining Contractual Term, Outstanding	2 years 11 months 15 days	3 years 10 months 21 days
Weighted-Average Remaining Contractual Term, Exercisable	2 years 11 months 15 days
Aggregate Intrinsic Value, Outstanding	$ 8,791,956
Aggregate Intrinsic Value, Exercisable	$ 8,791,956

Warrants (Details Textual)

Warrants (Details Textual) - USD ($)	1 Months Ended			12 Months Ended
	Jul. 31, 2019	Jul. 31, 2018	Jan. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Nov. 30, 2018	Jul. 26, 2018
Warrants (Textual)
Warrants exercise price per share				$ 0.00224
Estimated fair value charges				$ 86,483
Deemed dividend				$ 28,933,472
Expected life				3 years
Cash exercises of warrants				$ 172,949	$ 637,230
Increased by additional paid in capital				$ 28,933,472
Series B Preferred Stock Offering [Member]
Warrants (Textual)
Warrants exercise price per share				$ 0.075
Warrants to purchase shares of common stock				568,118,340
Series A Preferred Stock [Member]
Warrants (Textual)
Warrants to purchase additional shares of common stock		6,000
Common Stock [Member]
Warrants (Textual)
Warrants to purchase shares of common stock		6,600,000	13,700,000	3,997,661
Warrants, common stock per share			$ 0.40			$ 0.075
Warrants [Member]
Warrants (Textual)
Warrants, description				The aggregate intrinsic value outstanding stock warrants was $8,791,956, based on warrants with an exercise price less than the Company's stock price of $0.005 as of December 31 2019, which would have been received by the warrant holders had those holders exercised the warrants as of that date.
Warrants exercise price per share			$ 0.20				$ 0.20
Warrants to purchase shares of common stock	26,000,000	26,000,000	250,000	1,555,160
Risk-free interest			2.49%
Dividend yield			0.00%
Volatility			112.14%
Expected life			5 years
Cashless exercise of warrants				12,686,249
Warrants [Member] | Series B Preferred Stock Offering [Member]
Warrants (Textual)
Warrants exercise price per share				$ 0.00224
Warrants to purchase shares of common stock				600,551,672
Warrants to purchase additional shares of common stock				2,729,734,691
Warrants, common stock per share				$ 0.00224

Stock Options (Details)

Stock Options (Details) - Stock Options [Member] - $ / shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Exercise Price	$ 0.49	$ 0.50	$ 0.76
Number of Options	27,621,765	27,371,765	14,378,432
0.20 [Member]
Exercise Price		$ 0.20
Number of Options		12,000,000
Vesting Terms		Immediately
0.36 [Member]
Exercise Price		$ 0.36
Number of Options		250,000
Vesting Terms		Immediately
0.40 [Member]
Exercise Price		$ 0.40
Number of Options		1,000,000
Vesting Terms		Immediately
0.075 [Member]
Exercise Price	$ 0.075
Number of Options	250,000
Vesting Terms	Immediately

Stock Options (Details 1)

Stock Options (Details 1) - Stock Options [Member] - $ / shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Number of Options	27,621,765	27,371,765	14,378,432
Remaining Life In Years	8 years 5 months 1 day	7 years 2 months 23 days
Number of Options Exercisable	27,621,765
0.01 - 0.25 [Member]
Number of Options	13,306,786
Remaining Life In Years	8 years 3 months 4 days
Number of Options Exercisable	13,306,786
0.01 - 0.25 [Member] | Minimum [Member]
Exercise Price	$ 0.01
0.01 - 0.25 [Member] | Maximum [Member]
Exercise Price	$ 0.25
0.26 - 0.50 [Member]
Number of Options	1,939,631
Remaining Life In Years	7 years 3 months 4 days
Number of Options Exercisable	1,939,631
0.26 - 0.50 [Member] | Minimum [Member]
Exercise Price	$ 0.26
0.26 - 0.50 [Member] | Maximum [Member]
Exercise Price	$ 0.50
0.51 - 0.75 [Member]
Number of Options	1,820,112
Remaining Life In Years	6 years 8 months 5 days
Number of Options Exercisable	1,820,112
0.51 - 0.75 [Member] | Minimum [Member]
Exercise Price	$ 0.51
0.51 - 0.75 [Member] | Maximum [Member]
Exercise Price	$ 0.75
0.76 - 1.00 [Member]
Number of Options	9,926,072
Remaining Life In Years	6 years 8 months 16 days
Number of Options Exercisable	9,926,072
0.76 - 1.00 [Member] | Minimum [Member]
Exercise Price	$ 0.76
0.76 - 1.00 [Member] | Maximum [Member]
Exercise Price	$ 1
1.01 - 2.00 [Member]
Number of Options	629,164
Remaining Life In Years	6 years 7 months 10 days
Number of Options Exercisable	629,164
1.01 - 2.00 [Member] | Minimum [Member]
Exercise Price	$ 1.01
1.01 - 2.00 [Member] | Maximum [Member]
Exercise Price	$ 2

Stock Options (Details 2)

Stock Options (Details 2) - Stock Options [Member] - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Shares, Outstanding	27,371,765	14,378,432
Shares, Grants	250,000	13,250,000
Shares, Exercised		(256,667)
Shares, Forfeiture/Cancelled
Shares, Outstanding	27,621,765	27,371,765
Shares, Exercisable	27,621,765
Weighted-Average Exercise Price, Outstanding	$ 0.50	$ 0.76
Weighted-Average Exercise Price, Outstanding	0.49	$ 0.50
Weighted-Average Exercise Price, Exercisable	$ 0.49
Weighted-Average Remaining Contractual Term, Outstanding	8 years 5 months 1 day	7 years 2 months 23 days
Weighted-Average Remaining Contractual Term, Grants	8 years 5 months 1 day
Weighted-Average Remaining Contractual Term, Outstanding	7 years 5 months 27 days	8 years 5 months 1 day
Weighted-Average Remaining Contractual Term, Exercisable	7 years 5 months 27 days
Aggregate Intrinsic Value, Outstanding
Aggregate Intrinsic Value, Exercisable

Stock Options (Details Textual)

Stock Options (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Number of shares reserved for issuance, description		The Company had granted an aggregate of 60,600,000 securities under the Plans, with 3,900,000 shares available for future issuances.
Fair value of all options, vested	$ 14,000	$ 459,834
Unrecognized compensation expense	$ 0
Stock Options [Member]
Dividend yield		0.00%
Options to purchase of common stock	250,000
Fair value options to purchase of common stock		$ 2,146,193
Aggregate intrinsic value outstanding stock options	$ 0
Stock price	$ 0.005
Stock Options [Member] | Minimum [Member]
Risk-free interest		2.78%
Volatility		112.67%
Stock Options [Member] | Maximum [Member]
Risk-free interest		2.98%
Volatility		116.28%
Plan [Member]
Risk-free interest	2.43%
Dividend yield	0.00%
Volatility	114.00%
Expected life, description	Expected life of ten years and will be charged to operations over the vesting terms of the options.
Fair value options to purchase of common stock	$ 14,000

Income Taxes (Details)

Income Taxes (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Non-Current deferred tax asset: (Estimated)
Net operating loss carry-forwards	$ 17,520,826	$ 14,503,490
Valuation allowance	(17,520,826)	(14,503,490)
Net non-current deferred tax asset

Income Taxes (Details 1)

Income Taxes (Details 1)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Taxes Details 1Abstract
US federal statutory income tax rate	(21.00%)	(21.00%)
State tax – net of benefit	(5.00%)	(5.00%)
Non-deductible expenses, net of federal benefit	11.00%	11.00%
Increase in valuation allowance	15.00%	15.00%
Income tax expense

Income Taxes (Details Textual)

Income Taxes (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Taxes (Textual)
U.S. federal corporate income tax rate, description	The U.S. federal corporate income tax rate from 35% to 21%.
Federal income tax of net operating loss carry forward	$ 95,028,293
Operating loss carry forward expiring	Dec. 31, 2033
Tax benefit pecentage	50.00%
Description of ownership percentage changes	In general, an ownership change occurs whenever the percentage of the shares of a corporation owned, directly or indirectly, by 5-percent shareholders, as defined in Section 382 of the Code, increases by more than 50 percentage points over the lowest percentage of the shares of such corporation owned, directly or indirectly, by such 5-percent shareholders at any time over the preceding three years.
Provision for income taxes and the expected tax benefit using the federal statutory rate	21.00%	21.00%
Minimum [Member]
Income Taxes (Textual)
Increase decrease deferred tax valuation allowance	$ 14,503,490
Maximum [Member]
Income Taxes (Textual)
Increase decrease deferred tax valuation allowance	$ 28,756,435

Related Party Transactions (Det

Related Party Transactions (Details) - Executive Officer [Member]	1 Months Ended
	Oct. 21, 2019USD ($)shares
Related Party Transactions (Textual)
Issuance of series C preferred stock | shares	1,000
Aggregate fair value amount | $	$ 10,000

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member] - USD ($)	Jul. 13, 2020	Jul. 08, 2020	May 03, 2020	Mar. 05, 2020	Jan. 08, 2020	Jan. 07, 2020	Jun. 26, 2020	Apr. 17, 2020	Mar. 17, 2020	May 13, 2020
Subsequent Events (Textual)
MassRoots issued shares of common stock								69,000
MassRoots recorded shares of common stock					$ 37,160,000
Issued for settlement of convertible debt and accrued interest, Shares										72,368,457
Convertible notes issued for exchange of shares				72,600		55,000		330,000	17,600	82,268
Convertible notes value issued for exchange of shares				$ 6,600		$ 5,000		$ 30,000	$ 1,600
Debt interest rate, percentage			1.00%
Debt maturity date	Jan. 13, 2021	Dec. 31, 2020	May 31, 2022				Jul. 26, 2022
Principal interest and default penalties			$ 50,000
Issued and sold promissory note aggregate principal amount	$ 110,000	$ 22,911					$ 60,000
Annual interest rate, percentage		10.00%					10.00%
Original issuance discount	$ 10,000